赵澄泉，医学博士，UPMC-中国企业病理部主任。美国匹兹堡大学医学院教授，妇病理学/乳房病理学和细胞病理学专家,细胞病理学共同主任。
青岛医学院77级医学系学生，1983年毕业后留校在青岛医学院附属医院检验科工作曾任检验科副主任。

学习及工作经历：

1985-1988年在青岛医学院微生物硕士学习，随留校在微生物学和免疫学教研室任教。

1992年赴以色列希伯来大学从事DNA重组的分子生物学研究。

1993.10-2000.06在美国加州大学洛杉矶分校医学院(UCLA)从事抗菌肽分子生物学研究。科研成果获三项美国国家专利局专利。

2000.07开始在美国Drexel大学医学院接受四年病理学训练。后在美国国防部部队病理学研究院（AFIP）完成一年的妇产科病理学和乳房病理学专科训练，和在南加州大学(USC)专攻一年细胞病理学。

2006年至今，在匹兹堡大学医学中心Magee妇产科医院从事乳房病理学/妇产科外科病理学和细胞病理学的临床诊断，教学和科研工作，任细胞病理学共同主任，细针穿刺主任。因为工作和科研成绩突出，经过6年，由助理教授，副教授，破格晋升为匹兹堡大学医学院正教授。

科研方向：

妇科肿瘤的病理诊断和分子生物学及妇科宫颈细胞学，HPV的研究。

科研论文：

现有2个NIH-R01研究课题做为共同研究者。已发表医学论文170余篇，论文摘要120篇。会议宣读科研和受邀讲课100余次。 

社会职务：
现为多个病理学学会会员，美国病理学院(CAP) 细胞病理学委员会委员，ASCCP学会国际教育及拓展委员会委员，美国细胞病理学学会几个委员会委员。参入2013 WHO妇科肿瘤分类的编写。任大约20家英文医学杂志编委或特约审稿人。
积极参入中国国内病理医生教育活动，兼任上海复旦大学妇产医院，中国人民解放军301总院，中南大学湘雅医院，山西医科大学第二临床医学院，新乡医学院等多所中国国内大学和医院特聘/客座教授。中国优生科学协会阴道镜和宫颈病理学分会(CSCCP) 首席海外医学顾问，中华妇产科学会病理组/中国医疗保健国际交流促进会海外顾问, 中国病理学杂志编委会海外编委。

编译著作：

主编和叁入国内多部医学书籍的编写和翻译。主编妇科细胞病理学诊断与临床处理；细针穿刺细胞病理学；非妇科脱落细胞病理学, 乳腺病理诊断和鉴别诊断；实用妇科细胞学教程。翻译英文专著任主审Blaustein女性生殖道病理学(第6版）；乳腺病理活检解读；乳腺病理诊断难点；乳腺病理活检解读(第2版)，子宫颈和子宫体活检解读（第2版），现代阴道镜学。积极参入中国病理网络教学和培训，负责策划和编排网络学院《宫颈细胞病理学》，《细针穿刺细胞学》,《脱落细胞学》课程。

CURRICULUM VITAE

Chengquan Zhao, M.D.

APPOINTMENTS AND POSITIONS

Professor of Pathology, University of Pittsburgh Medical School

Gynecologic/Breast Surgical Pathologist and Cytopathologist

Co-Director of Cytopathology, Director of Fine Needle Aspiration, Magee-Womens Hospital

Chief of Pathology, UPMC-China Enterprises.

Working hospitals:

Magee-Womens Hospital-UPMC; Shadyside Cancer Center-UPMC.

China: Actively involve pathology education in China

Guest/visiting professor:

General Hospital of People’s Liberation Army (301 hospital)/medical school, China

Women Hospital of Fuda University, China

Anhui Province Women and Children Hospital, Hefei, Anhui, China

BinZhou Medical College, Yantai, Shandong, China

Qingdao University, Shandong, China

Editorial board of Chinese Journal of Pathology

2016-current Magee-Women Hospital, UPMC，Co-Director of Cytopathology

2016-currentDepartment of Pathology, UPMC，Chief of Pathology, China-Enterprise

2012-9 -currentUniversity of Pittsburgh, School of Medicine， Professor of Pathology

EDUCATION

Jan 2013-June, 2013  UPMC and Katz Graduate School of Business, University of Pittsburgh Certificate of 2013 Marshall W. Webster Physician Leadership Program

TRAINING

CERTIFICATION AND LICENSURE

SPECIALTY CERTIFICATION:

Certifying Board Year:

American Board of Pathology, Cytopathology  September, 2006

American Board of Pathology, (combined AP/CP)   August, 2005

ECFMG January, 1998

MEDICAL OR OTHER PROFESSIONAL LICENSURE:

Licensing Board/State Year

Medical Board of California March, 2003

Board of Medicine, District of Columbia May, 2004

Bureau of Professional and Occupational Affairs, PA    May, 2004

SERVICE IN EDITORIAL BOARD AND JOURNAL REVIEWER

American Journal of clinical and experimental obstetrics and gynecology (senior editorial board)

American Journal of Clinical Pathology (editorial board)

Diagnostic Pathology (editorial board)

World Journal of Obstetrics and Gynecology (editorial board)

Journal of Cancer (editorial board)

International Scholarly Research Network Pathology (editorial board)

Open Journal of Obstetrics and Gynecology (editorial board)

Journal of Chinese Clinical Medicine (editorial board)

Dataset Paper in Medicine (editorial board)

Am J Clin Exp Obstetrics and Gynecology (editorial board)

Chinese Journal of Pathology (editorial board)

Huaxia Pathology Information Net, Chief Academic editor

American Journal of Obstetrics and Gynecology

Journal of Obstetrics and Gynecology Research

Journal of Ovarian Research

Cancer Cytopathology

Diagnostic Cytopathology

European Journal of Obstetrics & Gynecology and Reproductive Biology

International Journal of Biological Science

Applied Immunohistochemistry & Molecular Morphology

Gynecology Oncology

Human Pathology

Cytojournal

Cytopathology

Histology and Histopathology

Cancer Management and Research

International Journal of Women’s Health

Cambridge University Press (book proposal review)

HONORS

Title of Award; Year

Golda Meir Foundation Postdoctoral Fellow, Hebrew University      1992-1993

Outstanding Scientific Research Award, Qingdao Medical College1991

Young Scientific leader Trained by the Education Committee of Shandong Provinces 1990

United States Patent, Clavanins, #6040293 March 21, 2000

United States Patent, Clavanins, #6010876 January 4, 2000

United States Patent, Clavaspirins, #5998374December 7, 1999

Pap Cytology and Hybrid Capture 2 HPV DNA Testing in 234 Patients with Cervical Squamous Carcinoma Li Z, Gao M, Austin RM, Zhao C. 2011 best abstract award by Chinese American Pathologist Association

The award of Huaxia Education, Huaxia Pathology. March 2011.

Li Z, Gilbert C, Yang H, Zhao C. Histologic follow-up results in patients with Pap test findings of endometrial cells: Results from a large academic women hospital laboratory. 2012 best abstract award by Chinese American Pathologist Association

UPMC Department of Pathology Resident Research mentor award nomination, 2012

RESEARCH GRANTS INVOLVED

Title:  Alteration of 3D nuclear organization at nanoscale in breast tumorigenesis.

Principle Investigator: Yang Liu, PhD, University of Pittsburgh

Agency: National Cancer Institute

Agency Number: R01CA185363

Amount of funding: $1,272,488 total ($830,000 direct cost and $442,488 indirect cost).

Co-investigator

Percentage effort 4%

Years: 05/01/2014-04/30/2018

Title:  Novel nanoscale single-cell analysis of exfoliative cytology

Principle Investigator: Yang Liu, PhD, University of Pittsburgh

Agency: National Institute of Biomedical Imaging and Bioengineering

Agency Number: R01 EB016657

Amount of Funding: $1,332,074 total ($900,000 direct cost and $432,074 indirect cost).

Co-investigator

Percentage effort 9% for year 1-2; 13.5% for year 3-4

Years: 04/01/2013-03/30/2017

Title:  Nano-architecture based biomarkers for cervical cancer screening.

Principle Investigator: Yang Liu, PhD, University of Pittsburgh

Agency: National Cancer Institute

Amount of Funding: $359,478 total ($239,250 direct cost and $120,228 indirect cost).

Co-investigator

Percentage effort 10%

Years: 05/01/2012-04/30/2014

Title: The study on abnormal methylation on related cancer inhibitor genes in cervical cancer tissue

Principle Investigator: Yankui Wang, MD, Qingdao Medical University, School of Medicine

Agency: Chinese National Nature Science Grants

Starting in 2011. 600,000 RMB

The first co-investigator

2007 University of Pittsburgh Department of Pathology research grants: Cervical cancer screening and HPV infection.US$ 30,000

2008 University of Pittsburgh Department of Pathology research grants: Cervical cancer screening and HPV infection.US$ 30,000

2009 University of Pittsburgh Department of Pathology research grants: Cervical cancer screening and HPV infection.US$ 30,000

Title of Project: Defensins: Antimicrobial Peptides of Human Neutrophils

Principal Investigator: Robert Lehrer, MD

Agency: NIH/NIAID R37 AI22839-13

Funding Period: 12/1/94-11/30/02

Percent Effort: 15%

Amount of Funding: 223,161

Title of Project: Topical Protegrins to Prevent STDS and HIV Infection

Principal Investigator: Robert Lehrer, MD

Agency: NIH/NIAID P01 AI37945-03

Funding Period: 3/1/95-2/28/99

Percent Effort: 10%

Amount of Funding: 419,795

Title of Project: Antimicrobial Peptides of Leukocytes

Principal Investigator: Robert Lehrer, MD

Agency: NIH/Fogarty R03 TW00355-04

Funding Period: 2/1/97-1/31/00

Percent Effort:15%

Amount of Funding: 20,000

Title of Project: Salt-tolerant Antimicrobial Peptides

Principal Investigator: Robert Lehrer, MD

Agency: Cystic Fibrosis Foundation

Funding Period: 7/1/97/6/30/00

Percent Effort: 10%

Amount of Funding: 99,491

GeneBank:

From 1993-2000, found and sequenced about sixty cDNA or gene sequences of antimicrobial peptides from human and various species of animals. All of them were sent to the GeneBank database.

PUBLICATIONS

Books and Chapters

1.Diagnostic Exfoliative Cytology. Chief editors:Chengquan Zhao, Fang Fan, Rulong Shen, Min Yang. Beijing Science and Technology Press, China. First edition May 2016

2.Precancerous Lesions of the Gynecologic Tract. Chief editor Oluwole Fadare. Chapter 11 Cytology of cervical precancerous lesions. Zaibo Li, Chengquan Zhao. Spinger, 2015.

3.Pathological Diagnosis and Differential Diagnosis of Breast Lesions. Chief Editors: Xiangsheng Zhang, Hong Bu, Chengquan Zhao. People’s Medical Publishing House, China. May 2014.

4.Diagnostic Cytopathology-Fine Needle Aspiration. Chief Editors: Chengquan Zhao, Liron Pantanowitz, Min Yang.Beijing Science and Technology Press, China, 2014.

5.Schnitt, Laura Collins. Biopsy Interpretation of the Breast. Translation.Chief Revisers,  Chengquan Zhao, Huayie Ding, Xiaojun Zhou. Beijing Science and Technology Press, China.Second edition, 2014.

6.Clear Cell Tumours Chapter. 2014 WHO Classification of Tumours of the Female Genital Organs. Chief editor: Kurman R, Carcangiu ML, Herrington CS, Young RH.4^th Edit. WHO Press, 2014

7.Kurman R, Ellenson LH, Ronnett B. Blaustein’s Pathology of the Female Genital Tract. Six Edit. Chinese translation.Chief Revisers: Zhao C, Liu Ai, Yang W, Cao D. Beijing Science and Technology Press, China, 2014.

8.Human papillomavirus (HPV) infection and cervical lesions. Zhao C. Yang H, Means M, Khalbuss WE. Gynecological and Breast cytopathology board review and self-assessment. Chief Edit Khalbuss WE, Means M. Springer New York, 2013

9.Gynecological Cytopathology: Brief text book. Chief Editors: Min Yang, Yaohua Cao, Chengquan Zhao, Beijing Science and Technology Press, China.2014.

10.Gynecological Pathology, Chapter 28:Sex Cord-Stroma Tumor of Ovary. Liu A, Zhao C, Wang J, Zheng W. People’s Medical Publishing House, China, 2013

11.Fredenck C. Koerner. Diagnostic Problems in Breast Pathology. Translation. Chief Revisers: Ding H, Zou X, Zhao C. People’s Medical Publishing House, China, First Edition, July 2011

12.Stuart Schnitt, Laura Collins. Biopsy Interpretation of the Breast. Translation.Chief Revisers,  Ding H, Zhao C. Beijing Science and Technology Press, China.First edition, September 2010.

13.Gynecological Cytology: Diagnosis and Clinical management (Chinese)

Chief Editor, Zhao C, Yang M. Beijing Science and Technology Press, China. First edition August 2011.

Chapter 1. Austin RM, Yang M, Zhao C. History and future of gynecologic cytology screening for cervical carcinoma. Page 1-8

Chapter2.Yang M, Wang J, Zhao C. Cervvical cytology TBS reporting system. Page 9-13

Chapter3.Zhao C, Zhao S, Yu J. HPV infection and cervical lesions. Page 14-41

Chapter4.Zhao C, Zhao S. The collection and adequacy of the specimen. Page 42-59

Chapter5. Yang M, Zhao C.Normal cervical cytology. Page 60-87

Chapter6.Zhao C, Yang M. Microorganisms ad infections. Page 88-122

Chapter7.Yang M, Zhao C.Benign cervical lesions, artifact and contamination. Page 123-145.

Chapter8.Zhao C. Yang M, Li Q. Squamous cell abnormality.Page 146-208

Chapter9.Zhao C. Bansal M, Yang M, Li Q. Page 206-263

Chapter 10. Yu J. Zhao C. Unusual genital tract tumors and extrauterine tumors. Page 264-272

Chapter 11.Zhang S, Zhao C. Cervical cytology of pregnancy. 273-284

Chapter 12. Zhao C, Bansal M, Huang W.Anal cytology

Chapter 13. Zhao E, Zhang A. Zhao C. Colposcopic examination, findings, related histology and cytology. 302-320

Chapter 14. ASCCP guideline for the management of women with abnormal cervical screening test. Translator: Yang W,Reviser: Yang H, Zhao C. page 321-340

Chapter 16. Chen X, Zhao C. New technologies in cervical cytology. Page 348-357

Chapter 17. Chen X, Zhao C.Cytopathology quality control and quality assurance in the USA. Page 358-367

Chapter 18.Austin M, Zhao C. Novel approaches for screening in the post-vaccine era. Page 368-374

Chapter 19. Austin RM, Zhao C.Lesson learned from the USA Pap test litigation: Perspective from over 200 litigation cervical cancer cases. Page 375-393

Chapter 20. Chen X, Zhao C.Introduction of gynecological cytology proficiency test. Page 394-399

Chapter 21.Yang M, Zhao C. Common abbreviation and brief introduction in gynecological cytology and histology. Page 400-409

Refereed Articles:

1.Zhao C, Crothers BA, Ghofrani, M, Li Z, Souers, RJ,Mojtaba Hussain, M,Fan F, Tolgay Ocal I, Goodrich K, Shen R, Davey DD. CAP Cytopathology Committee. Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists’ National Survey. Arch Pathol Lab Med, Accepted April 2016.

2.Pradhan D, Li Z, Ocque R, Patadji S, Zhao C (corresponding). Clinical Significance of Atypical Glandular Cells in Pap Tests: Analysis of Over 3000 Cases in a Large Academic Women Center. Cancer Cytopath. Accepted March 2016.

3.Zhao C, Crothers BA, Ghofrani, M, Li Z,Souers, RJ,Mojtaba Hussain, M,Fan F, Tolgay Ocal I, Davey DD. CAP Cytopathology Committee. HSIL Misinterpretation Papanicolaou Test Rates in the College of American Pathologists Gynecologic PAP Education and PAP Proficiency Test Program. Arch Pathol Lab Med, Accepted January 2016.

4.Zhao C, Crothers BA, Ghofrani, M, Li Z,Souers, RJ,Mojtaba Hussain, M, Fang Fan F, Tolgay Ocal I, Goodrich KM, Shen R, Davey DD. CAP Cytopathology Committee. Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey. Arch Pathol Lab Med, Accepted Feb 2016.

5.Tao X, Austin R, Zhang H, Zhang L, Xiao J, Wang L, Zhou X, Zhao C (corresponding). Pap Test Reporting Rates for Conventional Smear and Liquid-Based Cervical Cytology from the Largest Academic Women’s Hospital in China: Analysis of 1,248,785 Papanicolaou Test Reports. Acta Cytologica. 2016 Jan 21 Epub ahead of print.

6.Zhengyu Zeng, Huaitao Yang, Zaibo Li, Xuekui He,Christopher C. Griffith,Xiamen Chen,Xiaolei Guo,Baowen Zheng, Shangwei Wu,Chengquan Zhao (corresponding). Prevalence and genotype distribution of HPV Infection in China: analysis of 51,345 HPV genotyping results from China’s largest CAP certified laboratory. J Cancer. Accepted 2016 Feb.

7.Zeng Z, Austin RM, He X, Chen X, Guo X, Zheng B, Wu S, Yang H, Zhao C (corresponding). Prevalence of high risk human papilloma virus infection in China: Analysis of 671,163 human papillomavirus test results from China’s largest CAP-certified laboratory. Am J Clin Pathol. Accepted in October, 2015.

8.Zheng B, Li Z, Liang X, Austin RM, Chen C, Yan S,Zhao C (corresponding). Squamous Cell Carcinoma Cytology Reporting Rates and Histopathological Follow-up Results:the Experience of China’s Largest College of American Pathologists (CAP) Certified Clinical Laboratory. Acta Cytologica. 2015;59(5):399-404.

9.Zhao C (corresponding), Wu T, Ding X, Parwani A, Chen H, McHugh J, Piccoli A, Xie Q, Lauro GR, Feng X, Seethala RR, Wu S. Yousem S, Liang Y, Pantanowitz L. International Telepathology Consultation: Three Years of Experience between the University of Pittsburgh Medical Center (UPMC) and KingMed Diagnostics in China.J Pathol Inform 2015;6:63 (27 November 2015).

10.Tao X, Gu W, Zhou X, Zhao C. The diagnosis and the effort of molecular markers of ovarian tumors. Chin J Pathol. 2015:44(9):686-688.

11.Li Z, and Zhao C. Clinicopathological and immunohistochemical characterization of dedifferentiated endometrial carcinoma. Appl Immunohistochem Mol Morphol. 2015 Sep 14. [Epub ahead of print]

12.Li Z, Ranade A, Zhao C. Pathologic Findings of Follow-Up Surgical Excision for Radial Scar on Breast Core Needle Biopsy.Human Pathol 2016:48:76-80

13.Crothers BA, Darragh TM, Tambouret RH, Nayar R, Barkan GA, Zhao C, Booth CN, Padmanabhan V, Tabatabai ZL, Souers RJ, Thomas N, Wilbur DC, Moriarty AT. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire. Arch Pathol Lab Med. 2016;140(1):13-21

14.Stoler MH, Austin RM, Zhao C.Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years. J Clin Microbiol. 2015;53(9):2798-804.

15.Serdy K, Yildiz-Aktas I, Li Z, Zhao C (corresponding).The value of Papanicolaou tests in the diagnosis of endometrial carcinoma: a large cohort from an academic medical center. Am J Clin Pathol. 2016;145(3):350-354

16.Wang H, Li H, Xing X, Zhao C, Luo B. Genotypic analysis and latent membrane protein 1 expression of Epstein-Barr virus in extranodal NK/T-cell lymphoma from Northern Chinese patients.Arch Virol. 2015 Aug;160(8):2071-4.

17.Liang H, Griffith CC, Ma L, Ling B, Feng D, Li Z, Zhao C (corresponding). The sensitivity of Pap cytology and HPV testing to detect cervical cancer: prior testing results in 178 patients with invasive cervical cancer at a large general hospital in China. JASC 2016;5:64-70

18.Zheng B, Griffith CC, Yan S, Chen C, Ding X, Yang H, Zhao C (corresponding). Prior high risk HPV testing and Pap test results of 427 invasive cervical cancers in China’s largest CAP certified laboratory. Cancer Cytopathol. 2015;123(7):428-34.

19.Tao X, Griffith CC, Zhou X, Wang Z, Yan Y, Li Z, Zhao C (corresponding). History of high risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women’s hospital in China. Cancer Cytopathol. 2015;123(7):421-7.

20.Ocque R, Zhao C. Negative Pap, positive hrHPV: what we know so far. CAP Today 2015 May:48-49

21.Woodard A, Austin MR, Li Z, Beere J, Zhao C (corresponding). Prevalence of HPV16/18 genotypes and histopathologic follow-up outcomes in women with negative cytology and positive high risk HPV test results. JASC 2015;4:261-266

22.Liu S, Wang X, Shi Y, Han L, Zhao Z, Zhao C, Luo B. Toll-like receptor gene polymorphisms and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma in Northern China. Saudi J Gastroenterol. 2015;21(2):95-103

23.Zhao C (corresponding), Moriarty AT, Ghofrani M, Husain M, Tambouret RH, Laucirica R, Laser A, Fisher A, Ocal IT, Souers RJ, Russell DK, Fan F, Crothers BA. Human Papillomavirus testing and reporting rates in 2012: results of a College of American Pathologist’s (CAP) national survey. Arch Path Lab Med. 2015;139(6):757-61

24.Barron S, Austin RM, Li Z, Zhao C (corresponding): Follow-up outcomes in a large cohort of patients with HPV-negative LSIL cervical screening test results. Am J Clin Pathol 2015;143(4):485-491

25.Zheng B, Austin RM, Liang X, Li Z, Chen C, Yan S, Zhao C (corresponding). Positive predictive value (PPV) of a high grade squamous intraepithelial lesion (HSIL) cervical cytology result in China’s largest College of American Pathologists (CAP) certified laboratory. JASC 2015(4):84-89

26.Yang H, Xue D, Tao X, Li Z, Zhao C (corresponding). Human papilloma virus negative cervical cancer. Zhonghua Bing Li Xue Za Zhi. 2015;44(1):73-76.

27.Tao X, Zhou X, Zhao C. The advance of ovarian clear cell carcinoma in immunohistochemistry and molecular pathogenesis. Zhonghua Bing Li Xue Za Zhi. Accepted April 2015.

28.Fadare O, Zhao C, Khabele D, Parkash V, Quick CM, Gwin K, Desouki MM. Comparative analysis of Mapsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumurs. Pathology 2015;47(2):105-111.

29.Pantanowitz L, McHugh J, Cable W, Zhao C, Parwani AV. Imaging file management to support international telepathology. J Pathol Inform. 2015;6:17

30.Austin RM, Zhao C.Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening? Cytojournal. 2014 May 22;11:14

31.Zhao C (corresponding), Zaibo Li, Nayar R, Levi AW, Winkler B, Moriarty AT et al. Prior high-risk HPV testing and Pap test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multi-center study.Arch Pathol Lab Med. 2015;139(2):184-188.

32.Stoler MH, Austin RM, Zhao C. Cervical cancer screening should be done by primary HPV testing with genotyping and reflex cytology for women over the age of 25 years. J Clinical Microbiology. 2015 May 6 [Epub ahead of print].

33.Zhao C, Austin MR. The author’s reply. Am J Clin Pathol. 2014;142(2):279

34.Zheng B, Marshall Austin RM, Liang X, Li Z, Chen C, Yan S, Zhao C (corresponding). Bethesda System Reporting Rates for Conventional Pap Smears and Liquid-based Cytology in a Chinese Large College of American Pathologists Certified Independent Medical Laboratory: Analysis of 1,394,389 Pap Test Reports. Arch Pathol Lab Med. 2015;139(3):373-377.

35.HPV primary screening. Austin RM, Zhao C. CAP Today. 2014:11:

36.Marshall RM, Zhao C. Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening? Cytojournal. 2014, 11:14

37.Barron S, Li Z, Austin RM, Zhao C (corresponding). Low grade squamous intraepithelial lesion/cannot exclude high grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN2+ detection rates. Am J Clin Pathol. 2014;141(2):239-246.

38.Zhao C (corresponding), Hong W, Li Z, Weng B, Amin M, Austin RM. Human papillomavirus testing and cytologic/histopathologic “test of cure” follow-up results after excisional treatment for high grade cervical intraepithelial neoplasia. J Am Soc Cytopath. 2014; 3(1):15-20

39.Zhao C (corresponding). Yang H, Li Z. Evidence emerging for HPV-negative cervical cancer. CAP Today 2014;28(1):41-45

40.Zhao C 2014 PAPW: Online Education Activity, College of American Pathologists enduring internet CME Activity (February 17, 2014 to February 16, 2015)

41.Desouki MM, Lioyd J, Xu H, Cao D, Barner R, Zhao C (corresponding). CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Hum Pathol. 2013;44(11):2536-41

42.Crothers BA, Booth CN, Darragh TM, Zhao C, Souers RJ, Thomas N, Moriarty AT. False-positive papanicolaou (PAP) test rates in the College of American Pathologists PAP Education and Pap proficiency test programs. Arch Pathol Lab Med. 2014;138(5):613-619.

43.Li Z, Fadare O, Hameed O, Zhao C, Desouki MM. Incidence atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer. Hum Pathol, 2014;45:104-109.

44.Zhao C (corresponding), Li Z. Automated cell block system for atypical glandular cells of cervical cytology: Is it feasible? Cancer Cytopath 2014;122(1):5-7.

45.Kuhn E, Ayhan A, Bahadirli-Talbott A, Zhao C, Shih I-M. Molecular characterization of undifferentiated carcinoma associated with endometrioid carcinoma. Am J Surg Path. 2014;38(5):660-665

46.Darragh TM, Winkler B, Souers RJ, Laucirica R, Zhao C, Moriarty AT; College of American Pathologists Cytopathology Committee. Room for improvement: initial experience with anal cytology: observations from the College of American Pathologists interlaboratory comparison program in nongynecologic cytology. Arch Pathol Lab Med. 2013;137(11): 1550-1554.

47.Fasanella KE, Bista RK, Staton K, Rizvi S, Uttam S, Zhao C, Sepelveda A, Brand RE, McGrath K, Liu Y. Nuclear Nano-architecture Markers of Gastric Cardia and Upper Squamous Esophagus Detect Esophageal Cancer “Field Effect”. J Cancer. 2013 Sep 10;4(8):626-34

48.Zhao C (corresponding) Li Z, Austin RM. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia. Am J Clin Pathol. 2013;140(1):47-54.

49.Auger M, Khalbuss WE, Nayar R, Zhao C, Wasserman P, Souers R, Thomas N, Moriarty Ann. Accuracy and false-positive rate of cytologic diagnosis of follicular cervicitis: observation from the College of American Pathologists Pap educational program. Arch Pathol Lab Med. 2013;137(7):907-911

50.Li Z, Barron S, Hong W, Karunamurthy A, Zhao C (corresponding). Surveillance for Recurrent Cancers and Vaginal Epithelial Lesions in Patients with Invasive Cervical Cancer after Hysterectomy: Are Vaginal Cytology and HrHPV testing Useful. Am J Clin Pathol. 2013;140:708-714.

51.Cohen D, Austin RM, Gilbert C, Freij R, Zhao C (corresponding). Follow-up outcomes in a large cohort of patients with human papillomavirus-negative ASC-H cervical screening test results. Am J Clin Pathol. 2012;138(4):517-523.

52.Moriarty AT, Bentz JS, Winkler B, Fischer AH, Laucirica R, Souers R, Thomas N, Zhao C. Proficiency Testing of High Risk Human Papillomavirus DNA Tests: The first 3 years of experience of the College of Pathologists CHPV surveys. Arch Pathol Lab Med. 2013;137(5):606-609.

53.Zhao C, Yang M. The introduction of the US new screening guideline for cervical carcinoma. Chin J Obstet Gynecol 2013;48(5)

54.Gao FF, Bhargava R, Yang H, Li Z, Zhao C (corresponding). A clinicopathological study of serous tubal intraepithelial carcinoma and co-existing invasive carcinoma: Is the presence of STIC a reliable feature to determine organ of origin? Hum Pathol. 2013;44(8):1534-1543.

55.Desouki MM, Li Z, Hameed O, Fadare O, Zhao C (corresponding). Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women’s health center. Hum Pathol. 2013;44(9):1877-1881.

56.Zhao C (corresponding), Weng B, Li Z, Yang H, Austin RM. Follow-up outcomes of a large cohort of low-risk women with negative imaged liquid-based cytology and negative HPV test results. Am J Clin Pathol. 2013;139(1):32-38.

57.Zhao C. 2013 PAPW: Online Education Activity, College of American Pathologists enduring internet CME Activity (February 17, 2013 to February 16, 2013)

58.Li Z, Zhao C. (corresponding).Long-term follow-up results from women with cervical adenocarcinoma-in situ treated by conization: an experience from a large academic women’s hospital. JLGTD. 2013;17:452-458

59.Li Z, Jie, Zheng H, Zhao C. The clinical significance and treatment for women with endometrial cells in Pap tests. Chin J Pathol. 2013;42:

60.Zhao C (corresponding), Yang H. Human papillomavirus DNA detection in women with normal and abnormal cervical Pap cytology. Diagnostic Histopathology. 2012;18(8):341-347.

61.Zhao C. Li Z. endometrial cells in Pap tests-when are they significant? CAP Today 2013 January.

62.Zhao C, Yang H. Approved assays for detecting HPV DNA-design, indications, and validation. CAP Today 2012:26(1):40-44

63.Zhao C (corresponding), Yang H, Xie D, Yang M. HPV detection and histological findings in women with different Pap test results. Chin J Pathol. 2012;41(11):774-778

64.Nie Y, Sun Y, Wang Y, Liu C, Zhao C, Luo B. Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patients. Arch Virol. 2013;158(5):1031-7

65.Zhao C (corresponding), Yang H, Tian Z, Huang B. FDA approved HPV DNA detection methods, design, indication, and validation. Chin J Pathol; 2012;41(12):855-857.

66.Alexandrov SA, Uttam S, Bista RK, Zhao C, Liu Y. Real time quantitative visualization of 3D structural information. Opt Express. 2012;20(8):9203:14.

67.Zhao C (corresponding), Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM. Cytology and HPV screening test results associated with 2827 histopathologic cervical intraepithelial neoplasia 2/3 diagnoses. Arch Pathol Lab Med. 2012 Oct. Epub ahead of print.

68.Zhao C (corresponding), Desouki MM, Florea A, Mohammed K, Li X, Dabbs D. Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification. Am J Clin Pathol. 2012;138:72-78

69.Liu X , Tang X, Wang Y, Wang X, Zhao C, Luo B. Methylation and expression of retinoblastoma1 and transforming growth factor-β1 genes in Epstein-Barr virus-associated and –negative gastric carcinomas. Gastroenterology Research and Practice. 2012;2012:906017. Epub 2012 Sep 12.

70.Heravi-Mussavi A, Anglesio MS, Cheng SWG, Senz J….Young RH, Zhao C, ….Morin GB, Huntsman DG. Recurrent somatic DICER1 mutations in non-epithelial ovarian cancers. New Engl J Med 2012;366:234-242

71.Austin RM, Zhao C. Unrecognized risks associated with new cervical screening guidelines for younger women. Arch Pathol Lab Med. 2011;135(9):1080

72.Austin RM, Zhao C. Type 1 and Type 2 cervical carcinomas: Some cervical carcinomas are more difficult to prevent with screening. Cytopathology 2012;23(1):6-12

73.Wu C, Wang Y, Chao Y, Jia Y, Zhao C, Luo B. Characterization of Epstein-Barr virus type I nuclear antigen 3C sequence patterns of nasopharyngeal and gastric carcinomas in Northern China. Arch Virol 2012;157:845-853.

74.Zhao C (corresponding), Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM. Cytology and HPV screening test results associated with 2827 histopathologic cervical intraepithelial neoplasia 2/3 diagnoses. Arch Pathol Lab Med. Accepted in June 2012

75.Zhang XS, Dong HY, Zhang LL, Desouki MM, Zhao C (corresponding). Xanthogranulomatous inflammation in the female genital tract. J Cancer 2012;3:100-106

76.Zhao C (corresponding), Domfeh A, Austin RM. Histopathologic outcomes and clinical correlations for high risk patients screened with anal cytology.Acta Cytol.2012;56(1):62-7. Epub 2012 Jan 4.

77.Mona Bansal, Li Z, Zhao C (corresponding). Correlation of histopathologic/cytologic follow-up findings with vaginal ASC-US and ASC-H Pap test and HPV test results. Am J Clin Pathol. 2012;137;437-443

78.Li X, Weaver O, Desouki MM, Dabbs D, Shyu S, Carter G, Zhao C (corresponding). Microcalcification Is An Important Factor in the Management of Breast Introductal Papillomas Diagnosed on Core Biopsy. Am J Clin Pathol. 2012;138(6):789-795

79.Li Z, Yang H, Gilbert CM, Zhao C (corresponding). Histologic follow-up in patients with Pap test findings of endometrial cells: results from a large academic womens hospital laboratory. Am J Clin Pathol.2012;138:79-84

80.Li Z, Austin RM, Guo M, Zhao C (corresponding). Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma. Arch Pathol Lab Med.2012;136(12):1533-1540.

81.Mentrikoski MJ, Zhao C, Zhang J, Wang HL, McMahon LA, Yang Q, Li F, Xu H. Metastatic endometrial stromal sarcoma of the lung: importance of immunohistochemical staining, clinical history and imaging studies. Biotechnic & Histochem. 2012;87:35-39.

82.Austin RM, Zhao C. How should “negative” HPV LDT results be verified? Am J Clin Pathol. Accepted April 2012.

83.Zhao C, Yang H. FDA Approved assays for detecting HPV DNA: design, indication, and validation. CAP today. 2012;26(1):40-44

84.Bansal M, Austin RM, Zhao C (corresponding). Correlation of Histopathologic Follow-up Findings with Vaginal Human Papillomavirus and LSIL Pap Test Results. Arch Pathol Lab Med. 2011;135:1545-1549

85.Rao J, Levin M, Zhao C. Premature conclusion on HPV-only testing. Lancet Oncol 2011;12(11):992-993

86.Cheng JZ, Zhang JP, Yin XG, Li GX, Xu LH, Yang YL, Zhao C, Ren XC, Xue DB. Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor2 Expression in Invasive Apocrine Carcinomas of the Breast. Journal of Bengbu Medical College 2011;36(8)

87.Gao F, Austin RM, Zhao C (corresponding). Histopathologic follow-up and human papillomavirus DNA test results in 290 Patients with high grade squamous intraepithelial lesion papanicolaou test results. Cancer Cytopathol. 2011;119(6):377-386

88.Zhao C (corresponding), Chen X, Agnieszka OA, Kanbour A, Austin RM. Follow-up outcomes for a large cohort of U.S. women with negative imaged liquid based cytology findings and positive high risk human papillomavirus test results. Gynecol Oncol. 2011;122:291-296

89.Luo B, Tang X, Jia Y, Wang Y, Chao Y, Zhao C. Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in North China. Microbes Infect. 2011;13 (8-9):776-782

90.Austin RM, Zhao C. Observations for Pap litigation consultations. Pathology Case Reviews 2011;16:73-82

91.Zhao C (corresponding) Wu LSF, Barner R. Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer 2011;2:94-106.

92.Bansal M, Zhao C (corresponding). Prevalence of High Risk Human Papillomavirus in Women with Abnormal and Normal Vaginal ThinPrep Papanicolaou Cytology. J Low Genit Tract Dis. 2011;15(2):105-109

93.Bohn OL, Zhao C, Jones MW. Unusual Ovarian Stromal Tumor with Radiation Changes Mimicking Carcinoma. J Cancer 2011;2:228-231

94.Chao Y, Jing Y, Jia Y, Wang Y, Zhao C, Luo B. Conservation and mutation of viral interleukin-10 gene in gastric carcinomas and nasopharyngeal carcinomas. J Med Virol. 2011;83:644-650

95.Zhao C (corresponding),Zhao S, Heider A, Austin RM. Significance of high-risk papillomavirus DNA detection in women 50 years and older with squamous cell Pap test abnormalities. Arch Pathol Lab Med. 2010;134(8):1130-1135.

96.Zhao C (corresponding), Kalposi-Novak P, and Austin RM. Follow-up Findings in Adolescents with HSIL Pap Test Results. Arch Pathol Lab Med. 2011;135:361-364.

97.Heider, Austin RM, Zhao C (corresponding). Data From a Large University Womens Hospital Practice Support ASCCP Guidelines Citing HPV Triage As An Option with LSIL Cytology for Older Women. Acta Cytol . 2011;55:48-53

98.Fischer AH, Zhao C, Li QK, Gustafson K, Eltoum IE, Tambouret R, Benstein B, Savaloja L, Kulesza P. (American Society of Cytopathology Cell Biology Liaison Working Group). The Cytologic Criteria of Malignancy. J Cell Biochem. 2010;110(4):795-811.

99.Zhao C, Florea A, Austin RM. The utility of high risk HPV testing in women with atypical glandular cells. Arch Pathol Lab Med. 2010;134(1):103-108

100.Bandyopadhyay S, Austin RM, Dabbs D, Zhao C (corresponding).Adjunctive HPV DNA Testing Is a Useful Option in Some Clinical Settings for Disease Risk Assessment and Triage of Women with ASC-H Pap Results. Experiment Lab Med. 2010;28(1):3-5.

101.Bansal M, Austin RM, Zhao C (corresponding). High Risk HPV DNA detection in less than 2% of over 25,000 cytology negative imaged liquid based Pap test samples from women 30 and older. Gynecol Oncol.2009 115(2):257-61

102.Zhao S, Sun G ,MA De, Chen R, Dai H, Zhao C. Expression and Methylation Status of the Syk Gene in Cervical Carcinoma. Archives of Gynecology and Obstetrics.Arch Gynecol Obstet. 2011;238(5):1113-1119.

103.Cui Y, Wang Y, Liu X , Chao Y, Xing X-M , Zhao C, Liu C-Y , Luo B.Genotypical analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma from Northern China. Intervirology. 2010;54(3):131-138.

104.Wang Y, Liu X, Xing X, Cui Y, Zhao C, Luo B. Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China. VirusResearch. 2010;147(2):258-264.

105.Armah H, Austin RM, Dabbs D, Zhao C (corresponding). Follow-Up Findings in women with HPV-positive ASCUS Screening test results in a large women hospital. Arch Pathol Lab Med. 2009;133 (9):1426-30

106.Sohrab P. Shah, Martin Köbel, Janine Senz, Ryan Morin, Blaise Clarke,….Zhao C…..Marra M, Huntsman DG. Mutation of the FOXL2 gene in granulosa cell tumors of the ovary. New Engl J Med. 2009;360(26):2719-29.

107.Zhao C (corresponding),Florea A, Onisko A, Austin RM. Histologic fellow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic women hospital laboratory employing sensitive screening methods. Gynecol Oncol.2009;114(3):383-389.

108.Austin RM, Zhao C. Test group biases and ethical issues mar New England Journal of Medicine articles promoting HPV screening for cervical cancer in rural India. Cytojournal. 2009 Jul 16;6:12.

109.Zhao C (corresponding), Raza A, Martin SE, Pan J, Greaves TS, Cobb CJ. Breast Fine Needle Aspiration Samples Reported as “Proliferative Breast Lesion”: Clinical Utility of the Subcategory “Proliferative Breast Lesion with Atypia”.Cancer Cytopathol 2009;117:137-147.

110.Gur AS, Unal B, Zhao C, Johnson R, Edington H, Soran A. Lobular carcinoma in situ of the breast and ductoscopy. Breast J. 2010;16(3):318-320.

111.Zhao C (corresponding),Vinh TN. McManus K, David D, Barner R, Russell V. Comparison of 6 immunohistochemical sex cord-stromal markers within and between 5 types of ovarian sex cord-stromal tumors: Optimizing the selection of a panel of diagnostic markers. Am J Surg Pathol. 2009;33:354-366

112.Zhao C (corresponding) and Austin RM. High risk HPV DNA test result are useful for disease risk stratification in women with unsatisfactory liquid- based cytology Pap test results. J Low Genit Tract Dis. 2009;13(2):79-84

113.Bandyopadhyay S, Austin RM, Dabbs D, Zhao C (corresponding).Adjunctive HPV DNA Testing Is a Useful Option in Some Clinical Settings for Disease Risk Assessment and Triage of Women with ASC-H Pap Results. Arch Pathol Lab Med. 2008;132(12):1874-1881

114.Zhao C (corresponding) and Austin RM. Adjunctive high risk HPV DNA testing is a useful option for disease risk assessment in patients with negative Papnicolaou tests without an endocervical/transformation zone sample zone sample.Cancer. 2008;114:242-248

115.Zhao C (corresponding), Barner, R., Vinh, TN., McManus, K, David, D., Russell, V. SF1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian Sertoli cell tumor. Int J Gynecol Pathol. 2008;27(4):507-514

116.Zhao C (corresponding), Austin RM, Pan J, Barr N, Martin SE, Raza A, Cobb C. Clinical Significance of Atypical Glandular Cells (AGC) in Conventional Pap Smears in a Large High Risk U.S. West Coast Minority Population. Acta Cytol. 2009;53:153-159

117.Zhao C (corresponding) and Austin RM. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation Zone. Gynecol Oncol. 2007;107(2):231-235

118.Zhao C (corresponding),Elishaev E, Yuan KH, Yu J, Austin RM. Very low human papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests. Cancer. 2007;111(5):292-7

119.Zhao C (corresponding), Bratthauer GL, Barner R, Vang R. Diagnostic utility of WT1 immunostaining in ovarian Sertoli cell tumor. Am J Surg Pathol. 2007;31(9):1378-86

120.Vang R, Gown AM, Zhao C, Barry TS, Isacson C, Richardson MS, Ronnett BM. Ovarian mucinous tumor arising in association with mature cystic teratomas: Morphologic and immunohistochemical analysis identifies a subset that simulates secondary involvement by lower gastrointestinal tract mucinous tumors. Am J Surg Pathol. 2007;31(6):855-869.

121.Zhao C (corresponding), Bratthauer G, Barner R, Vang R. Immunohistochemical analysis of Sox9 in ovarian Sertoli cell tumors and other tumors in the differential diagnosis. Int J Gynecol Pathol. 2007;26 (1):1-9.

122.Zhao C (corresponding), BratthauerGL, Barner R, Vang R. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian Sertoli cell tumor from endometrioid tumors and carcinoid tumor:A study of 160 cases. Am J Surg Pathol. 2007;31(2):255-266.

123.Man YG, Zhao C, Wang J.Breast tumor cell clusters and their budding derivatives show different immunohistochemical profiles during stromal invasion: Implications for hormonal and drug therapies. Cancer Therapy. 2006;4:193-204.

124.Man YG, Zhao C, Wang J, Chen XL. A subset of prostate basal cells lacks corresponding phenotypic markers.Pathol Res & Pract. 2006;202(9):651-662.

125.Cole, A., Hong, T., Boo, L., Nguyen, T., Zhao C., Bristol, G., Zaack, J., Waring, A., Yang, O., and Lehrer, R.I.:A primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.Proc. Natl. Acad. Sci. USA. 99(4):1813-1818, 2002.

126.Lee, I.H., Zhao, C., Nguyen, T., Menzel, L., Sherman, M.A., Waring, A.J., Lehrer, R.I.:Clavaspirin, an antibacterial and hemolytic peptide from Styela clava.J Pept Res. 58:445-456, 2001.

127.Zhao, C., Nguyen, T., Boo, L., Hong, T., Espiritu, C., Orlov, D., Wang, W., Waring, A., and Lehrer, R.I.: RL-37, an alpha-helical antimicrobial peptide of the Rhesus monkey. Antimicrob agents chemother. 45(10):2695-2702, 2001.

128.Leonova, L., Kokryakov, V.N., Aleshina, G., Hong, T., Nguyen, T., Zhao, C., Waring, J.A., Lehrer, R.I:Circular minidefensins and post-translational generation of molecular diversity.J Leukoc Biol.70 (3):461-4, 2001.

129.Lehrer RI., Lee IH., Menzel L., Waring A., Zhao C.: Clavanins and styelins, alpha-helical antimicrobial peptides from the hemocytes of Styela Clava. Adv Exp Med & Biol. 484:71-6, 2001.

130.Zhao, C., Nguyen, T., Liu, L., Brogden, K., Sacco, R., Lehrer R.I.: Gallinacin-3, an Inducible Epithelial β-Defensin in the Chicken.Infect Immun. 69:2684-2691, 2001.

131.Lehrer, R.I., Nguyen, T.,Zhao, C., Ha, C.X., Glasgow, B.J.:Secretary Lipophilins: a tale of two Species.Ann N Y Acad Sci.923:59-67, 2000.

132.Zhao, C., Nguyen, T., Liu, L., Shamova, O., Brogden, K., Lehrer, R.I.:Differential expression of caprine β-defensins in digestive and respiratory tissues.Infec. Immun 67: 6221-4, 1999.

133.Shamova, O., Brogden, K., Zhao, C., Nguyen, T., Kokryakov., V.N. Lehrer, R.I.:Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Infect Immun. 67:4106-4111, 1999.

134.Zhao, C., Nguyen, T., Yusifor, T., Glasgow, B.J., Lehrer, R.I.: Lipophilins, a family of human Peptides homologous to rat prostatein (estramustine-binding protein). Biochem Biophys Res Commun 256:147-155, 1999.

135.Liu, L., Wang, L., Jia, H.P., Zhao, C., Heng, H.H.Q., Schutte, B., McCray, P.B., Ganz, T.: HBD-2 gene structure and expression at sites of inflammation. Gene. 222:237-244, 1998.

136.Zhao, C., Liaw, Lee, I.L., Lehrer, R.I.: The cDNA cloning of three cecropin-like antimicrobial peptides (styelins) from the tunicate, Styela clava.FEBS Lett. 412:144-148, 1997.

137.Liu, L., Zhao, C., Heng, H., Ganz, T.: The Human β-Defensin-1 and α-Defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics. 43:316-320, 1997.

138.Zhao, C., Liaw, L., Lee, I.L., Lehrer, R.I. :cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemolytic.FEBS Lett. 410:490-492, 1997.

139.Lee, I.H., Zhao, C., Cho, Y. Harwig, S.S.L., Cooper, E.L., Lehrer, R.I.:Clavanins, a-helical antimicrobial peptides from tunicate hemocytes. FEBS Lett. 400:158-162,1997.

140.Panyutich, A., Shi, J., Boutz, P.L. Zhao, C., Ganz, T.:Porcine PMN generates extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infec. Immun.65:978-985, 1997.

141.Zhao, C., Wang, I., Lehrer, R.I.: Widespread expression of beta-defensin hBD-1 in human secretary glands and epithelial cells.FEBS Lett. 396:3319-322, 1996.

142.Zhao, C., Ganz, T. and Lehrer, R.I.: The structure of porcine protegrin genes.FEBS Lett.368:197-202, 1995.

143.Zhao, C., Ganz, T. and Lehrer, R.I.:Structure of genes for two cathelin-associated antimicrobial peptides: Prophenin-2 and PR-39.FEBS Lett. 376:130-134, 1995.

144.Harwig, S.S.L, Kokryakov, V.N., Swiderek, K. M., Aleshina, G. M., Zhao, C., Lehrer, R.I.: Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes.FEBS Lett.362:65-69, 1995.

145.Reches, M., Zhao, C., and Engelberg-Kulka, H.:A bioassay based on recombinant DNA technology for determining selenium concentration.Appl. Environ. Microbiol. 60 (1):45-50, 1994.

146.Zhao, C., Reches, M., Depalo, D., St. Germain. D.L., and Engelberg-Kulka, H.: A recombinant DNA bio-assay for selenium in blood.Gene.148 (2):351-6, 1994.

147.Zhao, C., Liu, L., and Lehrer, R.I.: Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett. 246 (2-3):285-8, 1994.

148.Depalo, D., Kinlaw, W.B., Zhao, C., Englelberg-Kulka, H., and St. Germain, D.L.: Effect of selenium deficiency on type I 5’-deiodinase. J Biol Chem. 259 (23) 16223-8, 1994.

149.Zhao, C. (corresponding), Dai, S., and Shao, J.:Study of congenital cytomegalovirus, Hepatitis B virus, and toxoplasma infection.Acta Academiae Medicinae Qingdao, 27 (2):133-7, 1991.

150.Zhao, C. (corresponding), and Dai, S.:Study of the relation between toxoplasma infection and abnormal pregnancy.Acta Academiae Medicinae Qingdao.26 (4):286-90, 1990.

151.Zhao, C. (corresponding), and Dai, S. Study of Hepatitis B virus infection in 270 pregnant women and their infants.Acta Academiae Medicinae Qingdao.26 (2):140-1, 1990.

152.Zhao, C. (corresponding), and Shao, J.:Cytomegalovirus infection associated with transfusion in surgical patients.Acta Academiae Medicinae Qingdao.25 (2):116-8, 1989.

153.Zhao, C. (corresponding), Li, B., and Shao, J.:Human cytomegalovirus infection in patients with hematological disorders.Virological Sinica.4 (2):142-5, 1989.

154.Zhao, C.Cytomegalovirus infection in pregnant women and intrauterine propagation.Medicine and Philosophy.10 (3):38-40, 1989.

155.Zhao, C. (corresponding), Liu, Z., and Shao, J.: Detection of humeral immunity in patients with active cytomegalovirus infection.Shanghai journal of Immunology. 9 (1):32-3, 1989.

156.Zhao, C. (corresponding), Dai, S. and Shao J.:Study of cytomegalovirus infection in 276 pregnant women and their newborns.Chinese Journal of Obstetrics and Gynecology. 24:163-5, 1989.

157.Zhao, C. (corresponding), Shao, J., and Tiao, H.:Study of cytomegalovirus infection associated with blood transfusion in patients with hematological disorders. Chinese Journal of Hematology. 10 (6):283-4, 1989.

158.Zhao, C. (corresponding), and Shao, J.:Detection of specific antibodies to cytomegalovirus in the blood donors in Qingdao.Chinese Journal of Epidemiology. 10 (2):78-81, 1989.

159.Zhao, C.Blood transfusion and cytomegalovirus infection. Fascicle of Microbiology in Foreign Medicine.11 (2):53, 1988.

160.Zhao, C.Bone marrow transplantation and cytomegalovirus infection (review).Fascicle of Microbiology in Foreign Medicine. 11 (1):14, 1988.

161.Zhao, C. (corresponding), and Shao, J.Detection of anti-CMV IgM and IgA in women attending the prenatal clinic.Acta Academiae Medicinae Qingdao. 24 (3): 225-8, 1988.

162.Zhao, C. (corresponding), Yu, Y., and Xin, P.:Research of hepatitis B infection of donors in Qingdao City.Chinese Journal of Blood Transfusion. 1 (4):175-7, 1988.

Published Abstracts:

1.Zheng B, Austin RM, Liang X, Wan H, Wei G, Zhao C. Conventional Pap smear cervical screening in 11 rural counties in Hainan Providence, China: analysis of TBS reporting rate for 218195 screened women. J Low Genit Tract Dis 2016;20(2):S15. 2016 ASCCP Annual Meeting April 13-16, 2016. New Orleans, Louisiana

2.Chengquan Zhao, Xiang Tao, BaoWen Zheng, Fufen Yin, Christopher C Griffith, Zaibo Li, Bing Luo, Xiangdong Ding, Xianrong Zhou. PCR Human Papillomavirus Detection in Invasive Cervical Cancers with Prior Negative HC2 Test Results. Mod Pathol 2016;29(sup 2):124A USCAP 105st Annual Meeting, March 12-18, 2016, Seattle, Washington

3.Michelle Stram, Dinesh Pradhan, Chengquan Zhao. Prevalence of HPV 16/18 Genotypes and Histological Follow-Up Results in Women with Negative Pap Cytology/Positive Cervista HPV HR Assay.Mod Pathol 2016;29(sup 2):117A USCAP 105st Annual Meeting, March 12-18, 2016, Seattle, Washington

4.Chengquan Zhao, Dinesh Pradhan, Michelle Stram. Comparing the Histological Follow-Up Results between Positive HC2 HR HPV Test and Cervista HPV HR Assay for Women with ASC-US Cytology in a large Academic Women’s Hospital Practice. Mod Pathol 2016;29(sup 2):124A USCAP 105st Annual Meeting, March 12-18, 2016, Seattle, Washington

5.Xiang Tao, Marshall R Austin, Hao Zhang, Jianan Xiao, Lihong Zhang, Li Wang, Xianrong Zhou, Chengquan Zhao. The Pap Test Reporting Rates for Conventional Pap Tests and Liquid-Based Cervical Cytology from the Largest Academic Women’s Hospital in China: Analysis of 1248785 Papanicolaou Test Reports.Mod Pathol 2016;29(sup 2):118A USCAP 105st Annual Meeting, March 12-18, 2016, Seattle, Washington

6.Tao Wu, Christopher C Griffith, BaoWen Zheng, Xiangdong Ding, Yaoming Liang, Chengquan Zhao. Prior Pap Test and/or HPV Testing Results in 3342 Women with Histologically Diagnosed Cervical Intraepithelial Neoplasia 2/3: Data from China’s Largest CAP Certified Clinical Laboratory.Mod Pathol 2016;29(sup 2):121A USCAP 105st Annual Meeting, March 12-18, 2016, Seattle, Washington

7.BaoWen Zheng, Zaibo Li, Zhengyu Zeng, Congde Chen, Jia You, Lingyun Tan, Chengquan Zhao. High Risk HPV Testing and Report Rate: Result from the Largest CAP Certified Independent Laboratory in China.Mod Pathol 2016;29(sup 2):124A USCAP 105st Annual Meeting, March 12-18, 2016, Seattle, Washington

9.Zheng B, Li Z, Liang X, Chen C, Yan S, Zhao C. Squamous cell carcinoma cytology reporting rates and histopathologic gollow-up results: the experience of China’s largest CAP certified clinical laboratory. J Am Soc Cytopathol 2015;6(4):S32. 2015 American Society of Cytopathology Annual Meeting.Nov 13-16, 2015, Chicago, IL

8.Tao X, Zhang H, Zhao C. The Bethesda report rates for cervical cytology from the largest academic womens hospital in China. J Am Soc Cytopathol 2015;6(4):S31-32. 2015 American Society of Cytopathology Annual Meeting.Nov 13-16, 2015, Chicago, IL

10.Liang H, Griffith C, Ma L, Ling B, Feng D, Li Z, Zhao C. The sensitivity of Pap cytology and HPV testing to detect cervical cancer: prior testing results in 178 patients with invasive cervical cancer at a large general hospital in China. J Am Soc Cytopathol 2015;6(4):S33-34. 2015 American Society of Cytopathology Annual Meeting.Nov 13-16, 2015, Chicago, IL

11.Chengquan Zhao, Barbara A. Crothers, Mohiedean Ghofrani, Mojtaba Hussain, Fang Fan, Idris Tolgay Ocal, Diane D. Davey.HSIL Misinterpretation Papanicolaou test rates in the College of American Pathologists PAP Education and PAP Proficiency Test Program in 2013. Mod Pathol 2015;28(sup 2):115A. USCAP 104st Annual meeting, March 21-27, 2015, Boston

12.Chengquan Zhao, R. Marshall Austin.  Comparison of Cervista and Hybrid Capture 2 HPV detection rates in patients with LSIL and HSIL cytology results from the same FDA-approved collection vial.Mod Pathol 2015;28(sup 2):114A-115A USCAP 104st Annual meeting, March 21-27, 2015, Boston

13.Chengquan Zhao, Tao Wu, Xiangdong Ding, Anil V Parwani,William Cable, Hualin Chen, Jeff Mchugh, Qinling Xie, Gonzalo Romero Lauro,¹ Xiaodong Feng, Shangwei Wu,Samuel Yousem, Liron Pantanowitz . University of Pittsburgh Medical Center (UPMC) and Kingmed (China) International Telepathology Consultation: analysis of 1251 cases. Mod Pathol 2015;28(sup 2):403A USCAP 104st Annual meeting, March 21-27, 2015, Boston

14.Dinesh Pradhan, Stell Patadji, Chengquan Zhao. Clinical significance of atypical glandular cells on Pap test: Histological follow-up results of over 3000 women with AGC Pap in a large academic women center. Mod Pathol 2015;28(sup 2):103A USCAP 104st Annual meeting, March 21-27, 2015, Boston

15.Zaibo Li, Aditi Ranade, and Chengquan Zhao. Pathologic Findings of Follow-up Surgical Excision for Radial Scar on Breast Core Biopsy. Mod Pathol 2015;28(sup 2):54A USCAP 104st Annual meeting, March 21-27, 2015, Boston

16.Stell Patadji, Dinesh Pradhan, Chengquan Zhao. Significance of high risk Human Papilloma Virus detection in women with atypical glandular cells on Pap test: analysis of 1857 cases in single institute. Mod Pathol 2015;28(sup 2):102A USCAP 104st Annual meeting, March 21-27, 2015, Boston

17.Baowen Zheng, Zaibo Li, Shanshan Yan, Congde Chen, Xiangdong Ding,Xiaoman Liang, Huaitao Yang, Chengquan Zhao. Prior High Risk HPV Testing and Pap Test Results of 377 invasive Cervical Cancers in China’s Largest CAP Certified Laboratory. Mod Pathol 2015;28(sup 2):317A USCAP 104st Annual meeting, March 21-27, 2015, Boston

18.Zhengyu Zeng, R Marshall Austin,Xuekui He, Xianmei Chen, Xiaolei Guo,Shangwei Wu, Chengquan Zhao^. Prevalence of High risk Human Papilloma Virus Infection in China: analysis of 589,033 HPV test results from China’s largest CAP certified laboratory. Mod Pathol 2015;28(sup 2):114A USCAP 104st Annual meeting, March 21-27, 2015, Boston

19.Zhengyu Zeng, Huaitao Yang, Zaibo Li, Xuekui He,   Xianmei Chen,   Xiaolei Guo,Shangwei Wu,   Chengquan Zhao.  Prevalence and genotype distributions of HPV Infection in China: analysis of 51345 HPV tests from China’s largest CAP certified laboratory. Mod Pathol 2015;28(sup 2):113A-114A USCAP 104st Annual meeting, March 21-27, 2015, Boston

20.Xiang Tao, Zaibo Li, Xianrong Zhou, Zhiheng Wang, Yabin Yan,Chengquan Zhao. History of High Risk HPV Testing and Pap Test Results in a Large Cohort of Patients with  Cervical Carcinoma: Experience from the Largest Women Hospital in China. Mod Pathol 2015;28(sup 2):108A-109A USCAP 104st Annual meeting, March 21-27, 2015, Boston

21.Kate S, Yildiz-Aktas I, Li Z, Zhao C. The value of the ThinPrep test for endometrial carcinoma diagnosis: a large study cohort from an American medical center. JASC 2014;3(5):S2-3. 2014 American Society of Cytopathology annual meeting. Nov 14-17, 2014, Dallas, TX

22.Zheng B, Austin RM Liang X, Li Z, Chen C, Yan S, Zhao C. HSIL and squamous cell carcinoma cytology reporting rates and histopathologic follow-up results using different Pap test methods: The experience of China’s largest College of American Pathologists (CAP) certified clinical laboratory. JASC 2014;3(5):S47-S48. 2014 American Society of Cytopathology annual meeting. Nov 14-17, 2014, Dallas, HX

23.Zhao C, Moriarty AT, Tambouret RH, Ghofrani M, Husaub M, Laucirica R, Laser A, Fischer A, Ocal IT, Souers RJ, Russell DK, Crothers BA: College of American Pathologists Cytopathology Committee. HPV testing and reporting rates in 2012. Mod Pathol 2014;27(suppl 2):128A. USCAP 103st Annual meeting, March 1-7, 2014 San Diego, CA.

24.Zhao C, Wu T, Ding X. International telepathology consultation: an experience from UPMC and Kingmed (China). Mod Pathol 2014;27(suppl 2):404A-405A. USCAP 103st Annual meeting, March 1-7, 2014 San Diego, CA.

25.Zheng B, Liang X, Austin RM,Chen C, Yan S, Li Z, Zhao C. Comparison of Bethesda System reporting rates for liquid based cytology and conventional Pap smears in China’s largest CAP derrified laboratory: Analysis of 1,394,389 Pap reports. Mod Pathol 2014;27(suppl 2):128A. USCAP 103st Annual meeting, March 1-7, 2014 San Diego, CA.

26.Karunamurthy A, Jain S, Zhao C. Vaginal cytology in hysterectomized women with endometrial carcinoma, a larger cohort study from an academic women center. Mod Pathol 2014;27(suppl 2):107A. USCAP 103st Annual meeting, March 1-7, 2014 San Diego, CA.

27.Borron S, Li Z, Zhao C. Follow-up outcomes in a large cohort of patients with HPV-negative LSIL cervical Pap test. Mod Pathol 2014;27(suppl 2):96A. USCAP 103st Annual meeting, March 1-7, 2014 San Diego, CA.

28.Woodard A, Li Z, Austin M, Beere J, Zhao C.Histological follow-up outcomes and prevalence of HPV16/18 genotypes in women with negative cytology and positive high risk HPV test results in a large academic womens hospital laboratory. Mod Pathol 2014;27(suppl 2):127A. USCAP 103st Annual meeting, March 1-7, 2014 San Diego, CA.

29.Ranade A, Samrao D, Zhao C. Is routine surgical excision necessary for radial scar on core biopsy? A large retrospective study in an academic womens center. Mod Pathol 2014;27(suppl 2):77A. USCAP 103st Annual meeting, March 1-7, 2014 San Diego, CA.

30.Fadare O, Zhao C, Quick CM, Khabele D, Gwin K, Desouki MM. Comparative analysis of Napsin A, AMACR, and hepatocyte nuclear factor 1b as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 260 ovarian tumors. Mod Pathol 2014;27(suppl 2):282A. USCAP 103st Annual meeting, March 1-7, 2014 San Diego, CA

31.Zhao C, Ritu N, Levi AW, Winkler B, Moriarty AT, Barkan GA, Li Z, Rao J, Miller FS, Fan F, Si Q, Fisher A, Sturgis CD, Jing X, Marshall CB, Witt B, Crothers BA.Prior high-risk HPV testing and Pap test results of 58 invasive cervical carcinomas diagnosed in 2012. J Am Soc Cytopath 2013;2:S3. 2013 American Society of Cytopathology Annual Meeting.Nov 8-12, 2013, Orlando, Florida

32.Gilbert C, Freij R, Karunamurthy A, Li Z, and Zhao C. Follow-Up Outcomes of a Large Cohort of Low-Risk Women with ASC-US Imaged Liquid-Based Cytology and Negative HPV Test Results. Mod Path 2013;26(supp 2):90A-91A.2013 USCAP 102^st Annual Meeting, March 2-8, 2013, Baltimore, MD.

33.Zhao C, Li Z, Barron S, Hong W, Karunamurthy A. Vaginal cytology and HPV contesting is preferred for follow-up of women with invasive cervical cancer treated by hysterectomy. Mod Pathol 2013;26(sup 2):110A. 2013 USCAP 102th Annual Meeting. March 2-8, 2013, Baltimore, MD

34.Desouki M, Zhao C. Incidental high risk lesions in reduction mammaplasty specimen: analysis of 2351 cases from large women’s helth centers. Mod Path 2013;26(supp 2):36A. 2013 USCAP 102th Annual meeting, March 2-8, 2013, Baltimore, MD

35.Yildiz-Aktas I, Zhao C. Liquid-Based Papanicolaou Tests in Endometrial Carcinoma Diagnosis. Mod Path 2013;26(supp 2):109A.2013 USCAP 102^st Annual Meeting, March 2-8, 2013, Baltimore, MD.

36.Hong W, Li Z, Weng B, Amin M, Austin M, Zhao C.HPV testing and cytologic/histopathologic follow-up results after excisional treatment for high grade cervical intraepithelial neoplasia Mod Path 2013;26(supp 2):279A.2013 USCAP 102^st Annual Meeting, March 2-8, 2013, Baltimore, MD.

37.Barron S, Li Z, Austin RM and Zhao C. Low Grade Squamous Intraepithelial Lesion/Cannot Exclude High Grade Squamous Intraepithelial Lesion (LSIL-H): A Unique Cytologic Abnormality Mod Path 2013;26(supp 2):226A. 2013 USCAP 102^st Annual Meeting, March 2-8, 2013, Baltimore, MD.

38.Li Z, Gao F and Zhao C. PAX8 expression can be used to distinguish dedifferentiated endometrioid adenocarcinoma from grade III endometrioid adenocarcinoma Mod Path 2013;26(supp 2):286A.2013 USCAP 102^st Annual Meeting, March 2-8, 2013, Baltimore, MD.

39.Karunamurthy A, Jain S, Zhao C. The Utility of Vaginal Pap Test in Patients with Endometrial Carcinoma Post Hysterectomy.Mod Path 2013;26(supp 2):282A.2013 USCAP 102^st Annual Meeting, March 2-8, 2013, Baltimore, MD.

40.Kulhn E, Bahadirli-Talbott A, Ayhan A, Debeljak M, Eshleman J, Zhao C, Shih I-M. Molecular characterization of undifferentiated carcinomas that are associated with lw-grade endometrioid carcinoma. Mod Path 2013;26(supp 2):283A.2013 USCAP 102^st Annual Meeting, March 2-8, 2013, Baltimore, MD.

41.Li Z, Bhargava R, Yang H, Gao F, Zhao C (corresponding). Undifferentiated carcinoma of endometrium and ovary: morphological, immunohistochemical and clinical characteristics. Arch Path Lab Med 2012 136(9):1146. College of American Pathologists (CAP) 2012 Annual Meeting. San Diego, CA, September 9-12, 2012

42.Zhao C, Beere J, Yang H, Li Z, Austin RM. HPV16/18 prevalence and histopathologic follow-up findings in patients with negative or ASC-US liquid-based cytology (LBC) result. J Am Soc Cytopath 1(1S):S35. 2012 American Society of Cytopathology Annual Meeting. November 2-6, 2012 Las Vegas, NV.

43.Li Z, Zhao C. Long term cytologic and histologic follow-up result of adenocarcinoma-in situ of uterine cervix: results from a large academic women’s hospital. J Am Soc Cytopath 1(1S):S39. 2012 American Society of Cytopathology Annual Meeting. November 2-6, 2012. Las Vegas, NV.

44.Pantanowitz L, Khalbuss WE, Tseytlin E, Monaco SE, Zhao C, Cude J, Parwani AV, Mollow-Thoms C. Computer-assisted analysis of exploration strategies when viewing cytology whole slide images. J Am Soc Cytopath 1(1S):S7. 2012 American Society of Cytopathology Annual Meeting. November 2-6, 2012. Las Vegas, NV.

45.Chengquan Zhao (conresponding), Milon Amin, Baoying Weng, Xiangbai Chen, Amal Kanbour-Shakir, R Marshall Austin. Liquid-based cytology and high risk HPV screening test histories preceding 2827 histopathologic cervical intraepithelial neoplasia 2/3 Diagnoses. Mod Path 2012;25(supp 2):304A 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

46.Mohamed Desouki, Anca Florea, Khaled Mohammed, Xin Li, David Dabbs, Chengquan Zhao (conresponding). Routine Excision is Necessary for lobular Neoplasia Detected on Breast Core Needle Biopsy: Experience from a large Women Health Center. Mod Path 2012;25(supp 2):34A. 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

47.Xin Li, Mohamed M Desouki, David Dabbs, Susan Shyu, Gloria Carter, Lu Wang, Chengquan Zhao (conresponding),  Surgical excision may not be necessary for benign papillomas on core biopsy: a largest retrospective study in an academic women center. Mod Path 2012;25(supp 2):50A 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

48.Faye F.Gao, Bhargava Rohit, Haitao Yang, Zaibo Li and Chengquan Zhao (conresponding). Characteristic features of serous tubal intraepithelial carcinoma and its co-existing invasive carcinomas. Mod Path 2012;25(supp 2):272A2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

49.Huaitao Yang, Rohit Bhargava, Xiangbai Cheng, Faye Gao, Zaibo Li, Chengquan Zhao (conresponding),  Pelvic high grade serous carcinoma and association with serous tubal intraepithelial carcinoma. Mod Path 2012;25(supp 2):302A-303A 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

50.Zaibo Li, Huaitao Yang, Baoying Weng, Nancy Mauser,Chengquan Zhao (conresponding). Histologic follow-up results in patients with Pap test findings of endometrial cells: Results from a large academic women hospital laboratory. Mod Path 2012;25(supp 2):97A 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

51.Zaibo Li, Mona Bansal, Baoying Weng, Chengquan Zhao (conresponding). Follow-Up Findings of Abnormal Vaginal Pap Tests from Post-Hysterectomy Women and their Correlation with HPV DNA Test Results. Mod Path 2012;25(supp 2):282A-283A 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

52.David Cohen, R. Marshall Austin, Christopher Gilbert, Richard Freij, Chengquan Zhao (conresponding). Follow-up Outcomes in a Large Patient Cohort with HPV-negative ASC-H Computer-imaged Liquid-Based Cytology (LBC) Results. Mod Path 2012;25(supp 2):264A 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

53.Baoying Weng, Marshall Austin, Zaibo Li, Huaitao Yang, Mona Bansal, andChengquan Zhao (conresponding). Follow-up outcomes of a large cohort of low-risk patients with negative imaged liquid-based cytology and negative HPV test results. Mod Path 2012;25(supp 2):110A-111A 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

54.Gilbert CM, Lassige K, Matsko J, Mauser N, Austin RM, Parwani AV, Zhao C, Piccoli A, Pantanowitz L. Co-Reporting of HPV and Cytopathology Diagnoses in Pap Tests: Informatics Experience at a Large Academic Women’s Hospital. Mod Path 2012;25(supp 2):391A 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

55.Auger M, Khalbuss WE, Nayar R, Zhao C, Wasserman P, Souers R, Thomas N, Moriarty Ann. Accuracy and false-positive rate of cytologic diagnosis of follicular cervicitis: observation from the College of American Pathologists Pap educational program. Mod Path 2012;25(supp 2):82A 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

56.Moriarty AT, Bentz J, Fischer A, Laucirica R, Winkler B, Zhao C. on behalf of the College of American Pathilogists Cytopathology Committee. Proficiency testing of High Risk Human Papillomavirus DNA Tests: The first 3 years of experience of the College of Pathologists CHPV surveys. CytoJournal. 2011;8(supple):S42-S43. 2011 American Society of Cytopathology Annual Meeting. November 4-8, 2011, Baltimore, Maryland

57.Liu Y, Bista RK, Uttam S, Zhao C. Assessment of nuclear nano-architecture characteristics for cerivcal cancer screening. CytoJournal. 2011;8(supple):S102. 2011 American Society of Cytopathology Annual Meeting. November 4-8, 2011, Baltimore, Maryland

58.Zhao C (conresponding), Chen X, Onisko A, Weng B, Austin RM. Analysis of 70,123 cases with negative Pap test and high risk HPV co-test results in a large women hospital. CytoJournal 2011;8(supple):S53. 2011 American Society of Cytopathology Annual Meeting. November 4-8, 2011, Baltimore, Maryland

59.Chen X, Amin X, Zhao C (conresponding). Immunohistochemical features of large cell neuroendocrine carcinoma of the lung. Arch Pathol Lab Med.2011 CAP Annual Meeting, September 11-14, 2011. Dallas, Texas.

60.Zhao C (conresponding), Bansal M, Austin RM. Histopathologic Correlation Findings associated with (Post-Hysterectomy) Vaginal Pap and HPV Test Results. 2011 USCAP Annual Meeting, San Antonio, TX. Feb 26-March 4. Mod Pathol 2011;24 (suupl 1):273A

61.Lioyd J, Xu H, Zhao C (conresponding). CDX2 is a useful marker to distinguish ovarian primary carcinoid from metastasis. 2011 USCAP Annual Meeting, San Antonio, TX. Feb 26-March 4. Mod Pathol 2011;24 (suupl 1):258A

62.Amin M, Chen X, Austin RM, Zhao C (conresponding).  Cytology and HPV test results associated with 717 histopathologic diagnoses of CIN 2/3 at a large academic women hospital. 2011 USCAP Annual Meeting, San Antonio, TX. Feb 26-March 4. Mod Pathol 2011;24 (suupl 1):236A

63.Chen X, Monaco SE, Khalbuss WE, Zhao C (conresponding). The role of cytology in diagnosing large cell neuroendocrine carcinoma of the lung. 2011 USCAP Annual Meeting, San Antonio, TX. Feb 26-March 4. Mod Pathol 2011;24 (suupl 1):86A

64.Li Z, Austin RM, Guo M, Zhao C (conresponding). Pap cytology and hybrid capture 2 (HC2) HPV DNA testing in 234 patients with cervical squamous carcinoma. Pap Cytology and Hybrid Capture 2 (HC2) HPV DNA Testing in 234 Patients with Cervical Squamous Carcinoma.2011 USCAP Annual Meeting, San Antonio, TX. Feb 26-March 4. Mod Pathol 2011;24 (suupl 1):255A

65.Gao FF, Zhao C (conresponding). HPV DNA detection in the ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone in HSIL Pap tests ans subsequent histologic results. 2011 American Society of Cytopathology Annual Meeting, Boston, MA. September 12-16, 2010. Cancer (cytopath) 2010:118(5) suppl:336.

66.Gao FF, Austin RM, Zhao C (conresponding). Correlation of Papanicolaou test that are positive and suspicious for malignancy with follow-up histopathologic findings. Arch Path Lab Med 2010;134:1361 CAP 2010 Annual Meeting. September 26-29, Chicago, IL.

67.Zhao C (conresponding), Austin RM. Cytological results and clinical findings associated with 265 histopathological diagnoses of cervical glandular neoplasia: Results of 10 years. Mod Pathol 2010;23 (suppl 1):271A. 2010 USCAP Annual Meeting, March 20-26, 2010, Washington DC.

68.Florea AV (conresponding), Esposito NN, Dabbs DJ, Zhao C (conresponding).Lobular Neoplastia on breast core biopsy: Is routine excision indicated? A study of 353 cases. Mod Pathol 2010;23 (suppl 1):46A. 2010 USCAP Annual Meeting, March 20-26, 2010, Washington DC.

69.Zhao C (conresponding), Domfeh A. The distribution and frequency of abnormal anal Pap tests in HIV patients. Mod Pathol 2010;23 (suppl 1):109A. 2010 USCAP Annual Meeting, March 20-26, 2010, Washington DC.

70.Zhao C (conresponding), Domfeh A. Should patients with abnormal anal cytology have anal biopsy? A large retrospective series on HIV patients with abnormal anal cytology who had subsequent biopsy. Mod Pathol 2010;23 (suppl 1):173A. 2010 USCAP Annual Meeting, March 20-26, 2010, Washington DC.

71.Mentrikoski MJ, Zhao C, Zhang J, Wang HL, McMahon LA, Yang Q, Li F, Xu H. Metastatic endometrial stromal sarcoma in the lung: Importance of immunohistochemical staining, clinical history and imaging studies. Mod Pathol 2010;23 (suppl 1):409A. 2010 USCAP Annual Meeting, March 20-26, Washington DC.

72.Blansal M. Austin RM, Zhao C (conresponding). Histopathologic follow-up of women with post-hysterectomy LSIL vaginal Paps and high risk HPV testing. Mod Pathol 2010;23 (suppl 1):234A. 2010 USCAP Annual Meeting, March 20-26, 2010, Washington DC.

73.Bansal M, Zhao C (conresponding). High risk HPV detection and follow-up findings in women with vaginal ASC-US Pap tests. Mod Pathol 2010;23 (suppl 1):88A. 2010 USCAP Annual Meeting, March 20-26, Washington DC.

74.Zhao C (conresponding), Gao F, Bansal M. High risk HPV detection in women with abnormal vaginal Papanicolaou cytology. J Lower Genit Tract Dis.2010;14(3) 2010 American Society for Colposcopy and Cervical Pathology (ASCCP) Biennial Scientific Meeting. Las Vegas, NV, March 24-27, 2010.

75.Kanbour A, Zhao S, Kanbour-Shakir A, Zhao C. The previous history of cytological and histological abnormalities among women with negative computer-imaged liquid-based Pap and positive HPV DNA test results. J Lower Genit Tract Dis 2010;14(3) 2010 American Society for Colposcopy and Cervical Pathology (ASCCP) Biennial Scientific Meeting, Las Vegas, NV, March 24-27, 2010.

76.Zhao C (conresponding), Heider A, Austin RM. Significance of hrHPV Testing in Women Age 50 Years or Older with LSIL and HSIL Cytology. Arch Path Lab Med 2009;133(10):83. 2009 CAP annual meeting, Washington DC.Oct 2009.

77.Fasanella KE, Bista RK, Wang P, Holinga JA, Zhao C, Staton K, Brand RE, Liu Y. Optical analysis of columnar epithelial cells from gastric cardia predicts the presence of esophageal dysplasia and adenocarcinoma via quantitative phase microscopy. Kevin Mcgrath, Sa 1537, Gastrointestinal Endoscopy 73(4);, Digestive Disease Week 2011, May 7 – May 10, Chicago, IL

78.Zhao C (conresponding), Kalposi-Novak P, Austin RM. Histological follow-up finding in adolescents with HSIL cytology results. Cancer (cytopath) 2009;117(suppl):383.2009 American Society of Cytopathology Annual Meeting, November 2009 Denver, CO.

79.Fisher A, Benstein B, Gustafson K, King D, Kulesza P, Li QK, Neapolitano M, Zhao C (ASC Cell Liason Working Group). Classification of the Cytologic Criteria of Malignancy. Federation of American Societies for Experimental Biology (FASEB) Meeting, Saxtons River, Vermont, June.2009.

80.Zhao C (conresponding), Barnr R, Kurman R, Stamtakos M, Vang R. Clinicopathologic Analysis of Ovarian Clear Cell Carcinoma: Comparison of Cases with and without Adenofibromatous Components and Implications for Pathogenesis. Mod Pathol 2009;22 (suppl 1):242A, 2009 USCAP Annual Meeting, Boston, MA, March 7-13, 2009.

81.Zhao C (conresponding), Austin RM. Follow-up outcomes of cytological and histological abnormalities among women with negative computer-imaged liquid-based Pap and positive HPV DNA test results. Mod Pathol 2009;22 (suppl 1):99A, USCAP 2009 Annual Meeting, Boston, MA, March 7-13, 2009.

82.Kalposi-Novak, P, Zhao C (corresponding). Comparison of hrHPV prevalence in over 1300 computer-imaged liquid-based Pap Samples With and Without TZ/ECS. Mod Pathol 2009;22 (suppl 1):87A, USCAP 2009 Annual Meeting, Boston, MA, March 7-13, 2009.

83.Heider A, Austin RM, Zhao C (corresponding). Is HPV DNA Testing Useful for Women with LSIL Cytology? USCAP 2009 Annual Meeting, Mod Pathol. 2009;22 (suppl 1):217A, Boston, MA, March 7-13, 2009.

84.Zhao C (conresponding), Austin MR. Detection rates for high risk HPV DNA in women 50 and older with negative and abnormal Pap test results. Cancer Cytopath. 2008;114(5 suppl):366-367, 2008 American Society of Cytopathology Annual Meeting. Orlando FL, November 7-10, 2008.

85.Zhao C (conresponding), Austin MR. High risk HPV DNA detection rates in over 26,000 cytology negative imaged liquid-based Pap test samples. Cancer Cytopath 2008;114(5 suppl):366-367.2008 American Society of Cytopathology Annual Meeting. Orlando FL, November 7-10, 2008

86.Zhao C (conresponding), Austin RM. High risk HPV DNA testing is useful in women with unsatisfactory liquid-based cytology Pap tes results. J Lower Genit Tract Dis.2008;12(2):162. 2008 American Society for Colposcopy and Cervical Pathology (ASCCP) Biennial Scientific Meeting.Orlando, FL. March 17-21, 2008

87.Zhao C (conresponding), Vinh TN, McManus K, Dabbs D and Vang R. SF1 is Diagnostically Useful and Comparable to Other Sex cord-stromal Tumor Immunohistochemical Markers for the Differential Diagnosis of Ovarian Sertoli Cell Tumor. Mod Pathol 2008;21 (suppl 1):230A. 2008 USCAP Annual Meeting, Denver, CO.March 1-7, 2008.

88.Zhao C (conresponding), Vinh TN, McManus K, Dabbs D and Vang R. Comparative Immunohistochemical Analysis of Various Sex Cord-Stromal Markers in Different Categories of Ovarian Sex Cord-Stromal Tumors. Mod Pathol 21 (suppl 1):229A-230A, 2008. 2008 USCAP Annual Meeting, Denver, CO.March 1-7, 2008.

89.Austin MR and Zhao C (corresponding). Should Reflex hrHPV DNA Detection Be Performed in Women with ThinPrep Tests without TZ/ECS? Mod Pathol. 2008;21 (suppl 1):68A. 2008 USCAP Annual Meeting, Denver, CO.March 1-7, 2008.

90.Florea A, Austin RM and Zhao C (corresponding). Utility of High Risk HPV DNA (hrHPV DNA) Testing in Women with Atypical Glandular Cells. Mod Pathol 2008;21 (suppl 1):72A-73A. 2008 USCAP Annual Meeting, Denver, CO.March 1-7, 2008.

91.Armah HB, Austin RM, Dabbs D and Zhao C (corresponding).Follow-up Findings for Women with hrHPV DNA Positive ASC-US Pap Test Results in a Large Clinical Practice.Mod Pathol 2008;21 (suppl 1):195A. 2008 USCAP Annual Meeting, Denver, CO.March 1-7, 2008.

92.Dvorakova M, Austin RM, Dabbs D and Zhao C (corresponding). HPV DNA Detection in ThinPrep Pap Test Vials Is Independent of Cytologic Sampling of the Transformation Zone in HSIL Pap Tests and Subsequent Biopsy Diagnosis. Mod Pathol. 2008;21 (suppl 1):71A. 2008 USCAP Annual Meeting, Denver, CO.March 1-7, 2008.

93.Florea AV, Zhao X, Bandypadhyay S, Mauser N, Austin RM, Dabbs D and Zhao C (corresponding). Clinical Significance of Atypical Glandular Cells in Pap Smears: A Histologic Follow-up Study from an Older Age Demographic Population. Mod Pathol 2008;21 (suppl 1):73A. 2008 USCAP Annual Meeting, Denver, CO.March 1-7, 2008.

94.Feng Y, Wang X, Wang Y, Zhao C, Luo B. siRNA targeting LMP1-induced apoptosis in EBV-positive gastric epithelial cells is associated with inhibition of BCL-2 gene expression and promotion of Bax gene expression. American Society of Microbiology 108^th General Meeting, Boston MA. June 1-5, 2008

95.Bandyopadhyay, S., Austin, RM., Zhao C (conresponding). Hybrid capture 2 hrHPV DNA detection in ThinPrep Pap test vials in a very useful ancillary test in women with atypical squamous cells, cannot exclude HSIL (ASC-H). Cancer Cytopathol. 2007;111(5):379-380. 2007 American Society of Cytopathology Annual Meeting. Houston, TX. November 2-6, 2007

96.Huang, P., Hou, W., Grimaldo, S., Zhao C, Li, LY. Expression pattern of vascular endothelial growth inhibitor (VEGI) during angiogenesis in the ovary. The 18^th Annual UPMC Department of Pathology Research Day Presentations, Page 31, June, 2007.

97.Bandyopadhyay, S., Austin, RM., Zhao C (conresponding). Hybrid capture 2 hrHPV DNA detection in ThinPrep Pap test vials in a very useful ancillary test in women with atypical squamous cells, cannot exclude HSIL (ASC-H). The 18^th Annual UPMC Department of Pathology Research Day Presentations, Page 87, June, 2007.

98.Zhao C (conresponding), Martin SE, Pan, J., Greaves TS, Cobb C. Fine needle aspiration biopsy of proliferative breast lesions in patients with palpable mammary masses. A review of 172 cases and correlation with histologic diagnosis. Mod Pathol. 2007;20 (suppl 2) 88A-89A. 2007 USCAPAnnual Meeting, San Diego, CA. March 24-30, 2007

99.Zhao C (conresponding), Pan J., Barr N., Martin SE., Raza A., Cobb C. Clinical significance of atypical glandular cells in conventional smears. A histologic follow-up study from a large county hospital.Mod Pathol. 2007;20 (suppl 2) 89A. 2007 USCAPAnnual Meeting, San Diego, CA. March 24-30, 2007

100.Zhao C (conresponding), Bratthauer GL, Barner R., Vang R. WT1 is a useful immunohistochemical marker for the diagnosis of ovarian pure Sertoli cell tumor and facilitates distinction form other non-sex cord-stromal tumors in the differential diagnosis. Mod Pathol. 2007;20 (suppl 2) 219A. 2007 USCAPAnnual Meeting, San Diego, CA. March 24-30, 2007

101.Pan J, Zhao C, Cobb C, Greaves TS. Fine needle aspirationcytology of the thyroid follicular lesion: Correlation with histologic findings. Mod Pathol. 2007;20 (suppl 2) 79A. 2007 USCAPAnnual Meeting, San Diego, CA. March 24-30, 2007

102.Zhao C (conresponding), Bratthauer GL., BarnerR, Vang R.Immuhistochemical analysis ofSOX9 in ovarian Sertoli cell tumors and other tumors in the differential diagnosis.Mod Pathol.2006;19 (suppl 1) 203-204A. 2006 USCAP Annual Meeting. Atlanta, Georgia.February 11-17, 2006

103.Zhao C (conresponding), Vang, R., Bratthauer, GL., Barner, R.:Comparative analysis of alternate immunohistochemical markers for the distinction of ovarian Sertoli cell tumors from endometrioid tumors and carcinoid tumors: A study of 160 cases.Mod Pathol 2006;19 (suppl 1) 204A. 2006 USCAP Annual Meeting. Atlanta, Georgia.February 11-17, 2006

104.Vang, R., Gown, A., Zhao C, Barry, T., Ronnett, B.:Expression of CK7 and CK20 in ovarian mucinous tumors arising in association with teratomas: A CK7-/CK20+ subset can cause confusion with metastatic lower gastrointestinal (GI) tract mucinous tumors. Mod Pathol 2006;19 (suppl 1) 200A. 2006 USCAP Annual Meeting. Atlanta, Georgia.February 11-17, 2006

105.Zhao C (conresponding), Man, YG., Shen, T.Absence ofimmunophenotypic markers in morphologically distinct prostate basal cells.Am J Clin Pathol. 2005;124(4):658-659. 2005 American Society for Clinical Pathology (ASCP) Annual Meeting. Seattle, Washington. October 8-11, 2005

106.Tejani, A., Yousefi, M., Zhao C, Man, YG. Elevated expression of E-cadherin in cell clusters overlying focally disrupted breast myoepithelial cell layers. Am J Clin Pathol 2005;124(4):632-633. 2005 American Society for Clinical Pathology (ASCP) Annual Meeting. Seattle, Washington. October 8-11, 2005

107.Zhao C (conresponding), Barner, R., Vinh, T., Walker, A., Man, YG. A subset of normal and hyperplastic appearing human breast cell cultures exhibits similar immunohistochemical and cytological alterations to carcinoma cells. Mod Pathol. 2005;18(supple 1):57A. 2005 USCAP Annual Meeting, San Antonio, TX.February 26-March 4, 2005

108.Zhao C (conresponding), Mannion, C., Man, YG.:Potential roles of cytologic T-lymphocytes and nature killer cells in prostate basal cell layer disruptions and tumor invasion. Mod Pathol. 2005;18(supple 1):175A. 2005 USCAP Annual Meeting, San Antonio, TX.February 26-March 4, 2005

109.Man, YG, Vinh, T., Zhao C, Walker, A., Barner, R.:Potential roles of T-lymphocytes and nature killer cells in human mammary myoepithelial cell layer disruptions and tumor invasion. Mod Pathol. 2005;18(supple 1):42A. 2005 USCAP Annual Meeting, San Antonio, TX.February 26-March 4, 2005

110.Zhao C, Lee, I.H., Liaw, L., Menezel, L., Waring, A., Lehrer, R.I.: Styelins, antimicrobial peptides of tunicate hemocytes with homology to insect cecropins. Developmental and Comparative Immunology. 21:184, 1997.

111.Liu, Li., Heng, H., Zhao C, Ganz, T.Human B-defensin gene structure and chromosome location.J. Invest. Med. 44, 294 A, 1996.

112.Zhao C, Lehrer, RI.Structure of protegrin genes.17^th American Annual Phagocyte Workshop. San Diego, CA. May, 1995.

113.Reches, M., Zhao C, and Engelberg-kulka, H.:The use of new discoveries in the genetic code for a selenium bio-assay. Molecular Genetics of bacteria and Phages Abstracts, 1993;page 121. Cold Spring Harbor, New York, 1993.

114.Zhao C (corresponding) and Shao, J.:Study of congenital cytomegalovirus, Hepatitis B-virus, and toxoplasma infection.The Second Nation Congress of Virology.Abstract, Wuhan, China.May, 1991.

115.Zhao C (corresponding) and Dai S. Detection of Hepatitis B-virus marks in pregnant women and their offspring.The National Conference of Pregnant Women’s Inflammation. Guangzhou, China.December, 1989.

116.Zhao C (corresponding) and Shao J.Human cytomegalovirus infection in surgical patients resulting from transfusion.The Third China-Japan International Congress of Microbiology.Abstract, P. 155. Shanghai, China.August, 1988.

117.Zhao C (corresponding) and Shao J.Human cytomegalovirus infection associated with blood transfusion in 88 hematological patients.The Second National Congress of Medical Virology.Chengdu, China.October, 1988.

118.Shao, J., Wang, A., Zhao C, Li, Y. The relationship between the congenital cytomegalovirus. The Second National Congress of Medical Virology.Chengdu, China.October, 1988.

Meeting Presentation and Invited Lectures

1.PCR Human Papillomavirus Detection and Genotyping in Invasive Cervical Cancers with Prior Negative HC2 Test Results. USCAP 105st Annual Meeting, March 12-18, 2016, Seattle, Washington

2.Frozen of ovarian epithelial tumor: diagnostic challenge and pitfall. National Advanced Pathology Meeting by Beijing 301 Hospital, September 10-13, 2015, Beijing, China

3.A Practical Approach to Intraoperative Consultation in Breast Lesions. National Advanced Pathology Meeting by Beijing 301 Hospital, September 10-13, 2015, Beijing, China

4.Cervical cancer screening hot points: Is negative cervical cancer present? The 2015 Red House Forum. Shanghai, China, June 20-21, 2015

5.The introduction of current cervical cancer screening status in the USA. 2015 Chinese Annual Cytopathology Meeting. Hefei, China, June 12-14.

6.The introduction of current cervical cancer screening status in the USA. Xinxiang City First International Reproductive Medicine Meeting. Xinxiang, Henan China. June 9, 2015

7.Advanced IHC application in gynecological pathological diagnosis. Henan Province People Hospital. Zhengzhou, Henan, China. June 8, 2015

8.HSIL misinterpretation Papanicolaou test rates in the College of American Pathologists PAP education and PAP proficiency test program. Platform presentation at USCAP 104st Annual meeting, March 21-27, 2015, Boston

9.The morphologic and immunohistochemical features of ovarian tumor. Didactic Conference, Department of Gynecological/Obstetrics, UPMC, Feb 13, 2015

10.Immunostains in the diagnosis of gynecological tumors. First 301 Hospitals and UPMC Pathological Advance Conference. Co-Chair of the conference. Beijing, China. September 20-21 2014

11.Common problems in daily practice for breast pathology. First 301 Hospitals and UPMC Pathological Advance Conference. Co-Chair of the conference. Beijing, China. September 20-21 2014

12.The new American cervical cancer screening guideline and management guideline for abnormal Pap cytology. Advance in gynecological meeting. Beijing, China. September 27-28, 2014

13.The application of immunohistochemical study in the diagnosis of gynecological pathology. Chinese Society of Gynecological Pathology, Shanghai, China, May 17, 2014

14.Common problem in the diagnosis of breast pathology.Northern Area of Zhejiang Province 2014 Pathology Meeting. Jiaxing, Zhejiang, China. May 16, 2014.

15.The application of immunohistochemical study in the diagnosis of gynecological pathology.Northern Area of Zhejiang Province 2014 Pathology Meeting. Jiaxing, Zhejiang, China. May 16, 2014.

16.The application of immunohistochemical study in the diagnosis of gynecological pathology. Qingdao Association of Pathology, Qingdao, China, May 24, 2014.

17.Ovarian clear cell carcinoma, advance in morphology and molecular biology. Qingdao Association of Pathology, Qingdao, China, May 24, 2014.

18.The application of immunohistochemical study in the diagnosis of gynecological pathology. Zhongshan Cancer Hospital, Guangzhou, China May 23, 2014

19.HPV testing and reporting rates in 2012. USCAP 103st Annual meeting, March 1-7, 2014 San Diego, CA

20.Ovarian clear cell carcinoma, advance in morphology and molecular biology. The annual meeting of Chinese Pathology Association. Guangzhou, China. Nov. 8-10, 2013.

21.Ovarian serous carcinoma, diagnosis and pathogenesis. Huaxia Pathology Information Net, IPATHOLOGY. Dec. 14, 2013

22.Prior high-risk HPV testing and Pap test results of 58 invasive cervical carcinomas diagnosed in 2012. 2013 American Society of Cytopathology Annual Meeting.Nov 8-12, 2013, Orlando, Florida

23.Ovarian serous carcinoma, advances in pathogenesis. Didactic Conference, Department of Gynecological/Obstetrics, UPMC, Sept 27, 2013

24.The prevention of cervical cancer: history, presence and future. TianJin Hospital, YianJin, China, July 5, 2013.

25.Advanced morphological and molecular pathogeneses of ovarian serous tumor. Zhongshan Caner Hospital, Guangzhou, China, July 4, 2013

26.HPV infection and cervical cancer: several debatable questions. Kingmed medical ground round series. Guangzhou, China July 3, 2013

27.HPV infection and cervical cancer; fact and misunderstanding. The second Huaxia Pathology conference. Guilin, China June 29-30, 2013

28.The introduction of American updated cervical screening and management guidelines; The application of Pap test and HPV test in the prevention of cervical cancer. An-Bi-Ping Cytology course. Guilin, China, June 27-28, 2013

29.The relation of HPV infection and cervical carcinoma. Chinese People’s Liberation Army General Hospital. Beijing, China. June 25, 2013

30.Molecular pathogenesis of ovarian serous carcinoma. Chinese People’s Liberation Army General Hospital. Beijing, China. June 25, 2013

31.Cervical screening risk stratification with cytology and HPV testing. UPMC Cervical Cancer Screening: State-of the Art in 2013. Pittsburgh, PA April 19-20, 2013

32.Pathogenesis of ovarian cancers. Conemaugh Memorial Medical Center. December 8, 2012

33.The USA new cervical cancer screening guideline. National advanced course for female cervical cancer screening. Wuhan, Hubei, China October 22, 2012

34.Update on Pap tests, HPV detection, and follow-up findings. National advanced course for female cervical cancer screening. Wuhan, Hubei, China October 22, 2012

35.The most common important questions in the diagnosis of breast pathology. The second affiliated hospital of Anhui Medical School. Hefei, Anhui, China October 23, 2012

36.The history and current guideline for cervical cancer screening in the USA. Anhui Province Women and Children Hospital. Hefei, Anhui, China. October 24, 2012

37.The USA new cervical cancer screening guideline. Gynecological and Obstetrical Department, Affiliated hospital of Qingdao Medical School, Qingdao University. November 2, 2012

38.Pathology of breast papillary lesions, basic and updated. The Annual meeting of Qingdao Association of Pathology. Qingdao, China. November 3, 2012.

39.Pathogenesis of ovarian serous carcinoma: Advances in morphology and molecular pathology. The Annual meeting of Qingdao Association of Pathology. Qingdao, China. November 3, 2012.

40.Breast core biopsy with introduction of the experience at Magee-Womens Hospital, UPMC. The East Hospital of Qingdao Medical School, Qingdao University.China. November 5, 2012.

41.The history and current new guideline for cervical cancer screening in the USA. BinZhou Medical School, Yantai, China. November 7, 2012

42.Cervical cytology: Normal cytology and epithelial abnormality. Department of Pathology, Conemaugh Memorial Medical Center, May 19, 2012

43.Selected topic on current breast pathology practice (1). Huaxia Pathology Information Net, IPATHOLOGY. February 11, 2012

44.Selected topic on current breast pathology practice (2). Huaxia Pathology Information Net, IPATHOLOGY. February 14, 2012

45.Selected topic on current breast pathology practice (3). Huaxia Pathology Information Net, IPATHOLOGY. February 16, 2012

46.Uterine cervical Lesions: Benign and Malignant. Conemaugh Memorial Medical Center, February 25, 2012.

47.Routine Excision is Necessary for lobular Neoplasia Detected on Breast Core Needle Biopsy: Experience from a large Women Health Center. 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

48.Follow-up outcomes of a large cohort of low-risk patients with negative imaged liquid-based cytology and negative HPV test results. 2012 USCAP 101^st Annual Meeting, March 17-23, 2012 in Vancouver, BC, Canada.

49.Pathogenesis of ovarian cancer: advances in morphology and molecular pathology. Invited presentation, 17^th Congress of Chinese Society of Pathology and 1^st Annual Meeting of Chinese Pathologists Hangzhou, Zhejiang China October 21-23, 2011

50.Selected Topics on Current Breast Pathology Practice and Evaluating Issues: with the experience of Magee, UPMC. Invited presentation, The 3^rd National Symposium of Breast Pathology. Chengdu, China. August 13-15. 2011

51.Updated Breast Pathology Practice. Invited lecture, Pathology Meeting, Guangzhou, China August 19, 2011

52.The significance and clinical application of HPV detection in prevention and management of cervical lesions. Invited lecture, The Symposium of Prevention and Treatment of Cervical Cancers. Qingdao, China, August 21, 2011

53.Update on Pap tests, HPV detection and related Lab quality Assurance. Invited presentation, The 9^th Cytopathology Academic Conference of Chinese Medical Association. Changchun, China, August 27-28, 2011. Invited as General Meeting coordinator for half days.

54.Breast papillary lesions: Basis and update. Invited grand round lecture, Department of Pathology, Conemaugh Memorial Medical Center, June 4, 2011.

55.Update on Pap test, HPV testing and histologic findings. Invited Grand round lecture, Department of Pathology, UCLA, May 24, 2011.

56.Atypical Pap test and HPV infection. Invited grand round lecture, Gynecological Department, Magee Womens Hospital. January 13, 2011

57.Pathological Diagnosis on breast papillary lesions: Basis and update. Invited online lecture. Huaxia Pathology Information Net, IPATHOLOGY. December 12, 2010

58.Uterine corpus selected topics: epithelial tumors. Invited lecture, Department of Pathology, Conemaugh Memorial Medical Center, October 8, 2010.

59.Update on abnormal Pap tests, HPV detection and histological findings, with emphasis of Magee’s data. Grand rounds presentation, Department of Pathology, UPMC, September 16, 2010

60.The common problems on breast pathology. Department of Pathology, Conemaugh Memorial Medical Center. August 28, 2010

61.Selected breast diagnosis and evaluation issues in the USA.Invited lecture, Shanghai Jiaotong University, Rijin Hospital, Shanghai, China. June 24, 2010

62.A challenge for diagnosis: cervical glandular lesions. Invited lecture, The First Huaxia Pathology Symposium. Also as General Meeting Chair, Qingdao, China. June 18, 2010

63.Gynecological difficult Case Discussion. Invited lecture, The First Huaxia Pathology Symposium. Qingdao, China. June 19, 2010

64.HPV infection and cervical lesions. Invited lecture, Qingdao University Medical School Hospital. Qingdao, China. June 20, 2010.

65.Selected current breast practice and evaluation issue in the USA. Invited lecture, Chinese Military General Hospital 301, Beijing, China. June 10, 2010.

66.HPV infection in women with abnormal Pap tests, Invited lecture, Chinese Air force General Hospital, Beijing, China. June 10, 2010

67.The clinical management for women with abnormal Pap test results, ASCCP guideline. Invited lecture, Beijing Ditan Hospital, June 11, 2010

68.The evaluation of breast core biopsy in daily practice. Invited lecture, Shandong University Medical School. Jinan, China. June 13, 2010

69.Introduction of ASCCP management guideline for abnormal Pap findings. Invited lecture, Shandong University, Jinan, China, June 13, 2010

70.Cervical glandular lesion. Invited Grand round lecture, Drexel University, Philadelphia, April 27, 2010.

71.Histopathologic follow-up of women with post-hysterectomy LSIL vaginal Paps and high risk HPV testing. 2010 USCAP annual meeting, March, Washington DC.

72.Cytological results and clinical findings associated with 265 histopathological diagnoses of cervical glandular neoplasia: Results of 10 years. 2010 USCAP annual meeting, March, Washington DC.

73.Uterine epithelial tumor. Invited online lecture. Huaxia Pathology Information Net, IPATHOLOGY. September 29, 2009

74.Uterine Mesenchymal Tumor. Invited online lecture. Huaxia Pathology Information Net, IPATHOLOGY. July 25 2009.

75.The diagnosis and significance of atypical glandular cells in Pap tests. Invited Grand round lecture, Loma Linda University, Los Angeles, May 11, 2009.

76.The history and current role of breast fine needle aspiration in the USA. Invited lecture, Chinese 8^th National Cytopathology Meeting. March 28, 2009 Guangzhou, China

77.The clinical significance of atypical glandular cells in Pap tests and the HPV detection for AGC women. Invited lecture, Cytopathology Meeting, Cytopathology Association of Hong Kong, March 30, 2009

78.Clinicopathologic analysis of ovarian clear cell carcinoma: comparison of cases with and without adenocarcinomatous components and implications for pathogenesis. USCAP 2009 annual meeting. March 7-13, 2008. Boston, MA.

79.Is HPV DNA Testing Useful for Women with LSIL Cytology? USCAP 2009 Annual Meeting, March 7-13, 2008. Boston, MA.

80.Introduction of Pathology System in the USA. Online lecture. Invited lecture, Chinese Pathologists. IPATHOLOGY. December 13, 2008.

81.Atypical glandular cells in Pap test. Invited online lecture. Huaxia Pathology Information Net, IPATHOLOGY. November 1, 2008.

82.The introduction of ASCCP guideline. Invited lecture, Gynecological conference. Qingdao, China. October 11, 2008.

83.HPV detection and HPV vaccine. Invited lecture, Gynecological conference. Qingdao, China. October 11, 2008.

84.Atypical glandular cells and ASC-H on Pap tests: A challenge for diagnosis and management. Cytopathology Updates Meeting. Pittsburgh, PA. September 27, 2008.

85.High risk HPV DNA testing is useful in women with unsatisfactory liquid-based cytology Pap test results. March 17-21, 2008 American Society of Colposcopy and Cervical Pathology (ASCCP) Biennial Meeting, Orlando, FL.

86.Follow-up findings in women with HPV positive ASC-US screening test results in a large women hospital. USCAP annual meeting. March 2008. Denver,

87.Structure of protegrin genes.17^th Annual Phagocyte Workshop. San Diego, CA. May, 1995.

88.Detection of Hepatitis B-virus marks in pregnant women and their offspring.The National Conference of Pregnant Women’s Inflammation. Guangzhou, China.December, 1989.

89.Human cytomegalovirus infection in surgical patients resulting from transfusion.The Third China-Japan International Congress of Microbiology. Shanghai, China.August, 1988.